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ABSTRACT
During normal speech, human vocal folds sustain greater than 100 high impact collisions each
second. When the pliability of this complex biomechanical system is reduced by scarring,
voice quality may be compromised. Currently, little can be done to treat patients affected
with voice loss or chronic voice impairment due to scarring. Because of the size of the patient
population suffering from voice impairment secondary to scarring, alternate treatment
methods are currently being actively investigated. An implant-based approach is one strategy
for treating lamina propria scarring.
To rationally design an implant material for this purpose, it is important to have a more
complete understanding of lamina propria biochemistry and microstructure than is currently in
literature. This dissertation presents the following critical insights into normal human lamina
propria biochemical structure:
1.) quantitative analysis of collagen, elastin, hyaluronan, and proteoglycan presence;
2.) quantitative examination of the spatial distributions of collagen, elastin, and
hyaluronan, and qualitative investigation of the spatial distributions of specific
proteoglycan types; and
3.) assessment of total cellularity and spatial variations in extracellular matrix turnover.
Similar analyses have been carried out on the vocal fold lamina propria of normal dog, pig,
and ferret towards identifying an appropriate animal model for implant trials.
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Chapter 1. Motivation and Approach
1.1 Introduction to vocal fold anatomy and scarring
The human vocal folds are paired structures roughly 10-15 mm in length and 5mm thick,
which are brought into apposition across the airway for sound production. Each vocal fold is
a laminated structure consisting of pliable vibratory layer of connective tissue, known as the
lamina propria (LP), sandwiched between epithelium and muscle [1]. (See Figure 1.1).
epithelium
lamina propria
vocalis nmscle
Figure 1.1 Diagrammatic representation of a coronal section
through the midmembranous human vocal folds
The human LP is often further subdivided into the superficial (SLP), intermediate (ILP), and
deep (DLP) layers [2]. These subdivisions have traditionally been based on histologically-
observed changes in elastin and collagen concentration within human LP [3]. The
intermediate and deep layers, also known as the vocal ligament, are thought to be involved in
balancing the tension present in the vocalis muscle with that in the SLP [4]. The SLP is
believed to be the region of the vocal fold that sustains the most stress during vibration [5],
and most patients suffering from vocal fold scarring have trauma limited to this layer [6].
As air is forced out of the lungs, the muscle and overlying LP of the vocal folds are driven
into vibration, creating a quasi-periodic valving of air flow. During normal speech, human
vocal folds sustain greater than 100 high impact collisions per second [7]. Thus, the vocal
folds are vulnerable to mechanical damage or scarring from overuse and abuse of the voice.
Scarred SLP can also result from benign and malignant disease processes requiring ablative
surgery or radiation therapy, or from prolonged endotracheal intubation [8]. The altered
geometry and increased tissue stiffness associated with vocal fold scarring cause voice
changes ranging from hoarseness to complete voice loss. Since little can currently be done to
treat patients suffering from voice impairment secondary to scarring and because of the size
of this patient population, alternate treatment methods are currently being actively pursued [6,
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9-18]. One such alternate approach, and the one which has formed the underlying basis for
this project, is the use of an implant to restore normal function.
This intricate vibratory system has an additional layer of complexity that arises from the high
levels of neurological control needed to express emotional states through voice [19]. In fact,
voice and mind are so connected that psychological dysfunction can create voice dysfunction
in the absence of any vocal fold defect [20]. Or vice versa, the effects of LP abnormalities on
fold vibration can be markedly reduced by this same neurological input. This situation has
significant implications for the potential of implant-based strategies to restore functionally
normal voice as well as for methods that can be used to assess restoration quality.
Specifically, LP restoration does not need to be complete for near-complete functional
restoration to occur. At the same time, the intimate neurological control of the vocal folds
creates ambiguity in the use of phonation-based assessment tools for implant evaluation.
1.2 Current methods in scar treatment
Aspects of vocal fold scarring are currently addressed with a variety of surgical techniques,
from scar lysis to tissue replacement with flaps, grafts, and injectable materials [6, 14].
Whereas scar lysis, flaps, and grafts attempt to remove the scar tissue and/or replace it with
new tissue, injectable materials are used to augment the amount of "functional" tissue,
reducing the impact of the scarred portion on the overall vibration. Effectively, the implant is
meant to alter the mass distribution in and pliability of the scarred region of the LP so that
normal functionality is restored. Synthetic materials such as Teflon and silicone [21], and
biologically-related or derived materials, such as fascia [22], fat [23], and collagen [24], have
previously been used as augmentation substances. More recently, patients have been injected
with hylaform (hylan b), a modified form of hyaluronan [17].
Important starting points can be gained from these previous research studies, including that:
1.) biodegradable implant materials have generally been resorbed prior to generation of
lasting replacement tissue, and as such restoration has often been temporary; 2.) non-
biodegradable implant strategies have generally resulted in foreign body responses over the
long term, often exacerbating the scarring and voice dysfunction originally present [6, 14].
Beyond this, however, how voice outcome specifically relates to the chemical and structural
properties of a given implant material remains largely unclear, limiting the ability to predict
how modification of a given implant material will affect functional outcome.
This lack of clarity arises in part from the reliance on phonation-based assessment tools as
common measures of "success" in most of these implant trials. Although these criteria have
an intuitive appeal in that the desired output of the implant-"input" into the "host-implant
interactions" black-box is functional restoration of voice, relating these phonation-based
measures back to the implant material is complicated by the diverse variables that impact
voice. The result is that observed vocal range and quality and vibratory behavior cannot be
unambiguously correlated with the implant material and, thus, do not clearly indicate how a
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material should be changed to improve outcome. This additional level of insight requires
objective information concerning cellular level implant-host interactions. It is a goal of this
thesis is to identify and develop measurable "outputs" which not only are correlated with
vibratory function but also give key insight into implant-host interactions at the cellular and
microstructural level.
Two possible "outputs" sets that meet these joint criteria are: 1.) combined quantitative
biochemical and histological implant assessment, or 2.) combined biomechanical and
histological implant examination. These two sets are linked through the structure-function
relationship [25], which essentially states that, given appropriate biochemical composition
and microstructural information, a tissue's biomechanical properties can be predicted.
Results from implant analysis using either of these "output" sets could then be compared to
established benchmarks for normal LP, allowing objective evaluation of implant success and
insight into possible implant alterations to improve outcome.
A final comment needs to be made concerning the above listed "output" evaluation sets. It is
important to differentiate the biomechanical properties of the LP from vocal fold vibratory
behavior. Vocal fold vibration is a complex interplay between the underlying muscle, the
geometry and pliability of the LP, and neurological input. The biomechanical properties of
the LP would ideally be independent of the muscle vibratory behavior, vocal fold geometry,
and neurological input.
1.3. Current understanding of LP biochemistry and microstructure
In recent decades, a number of histological studies have been published which have
significantly advanced the understanding of LP biochemical composition and microstructure.
For example, the distributions of total collagen [26-31], elastin, [29, 30, 32-35], and general
mucopolysaccharides [34, 36] throughout the human LP have been well studied. Since these
molecules have key biomechanical functions, these studies have increased the insight into the
structure-function relationship of this tissue [4]. However, quantitative information is still
needed to better complete the functional picture sketched by this histological data. In fact, all
currently published protein-based biochemical studies of the LP have been qualitative, to the
author's knowledge.
A number of researchers have attempted to assess the mechanical properties of the LP. Most
of these studies have performed traditional bulk tensile tests on the LP or have assessed low
frequency LP viscoelasticity using cone and plate rheometry [29, 37-40]. However, it is not
clear how relevant these biomechanical measurements are in the context of the actual stresses
and strains sustained by the vocal fold lamina propria in its normal operating frequency range.
For example, it is unclear whether low frequency (<10Hz) data can be extrapolated to make
high frequency (>-OOHz) functional assessments. In addition, the relatively complex
macroscopic geometry of the LP makes the results from traditional bulk mechanical testing
techniques difficult to interpret reliably.
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1.4 Method of approach
Based on initial feasibility studies of biomechanical versus biochemical lamina propria
analyses, it was decided to pursue development of biochemical and microstructural /
histological benchmarks for normal vocal fold LP towards implant evaluation. Important
outcomes from these feasibility studies are discussed in Appendix A.
There are two approaches generally taken to studying tissue biochemistry: protein-based and
mRNA-based biochemical techniques. Although mRNA measures have substantial value in
elucidating the dynamic state of tissue cellular physiology, there is generally not a one-to-one
correlation between mRNA levels of a specific extracellular matrix (ECM) molecule and the
concentration of that molecule within the ECM [41]. With respect to first-order implant
evaluation schemes, understanding what is quantitatively present in the normal vocal fold LP
ECM is arguably of higher priority than elucidating the dynamic state of the cells. As such,
this thesis will focus on protein-based ECM biochemical quantitation.
The concentration and distribution of the following major biomolecules in the normal human
LP will be investigated: (1) total collagen, (2) elastin, (3) hyaluronan, and (4) proteoglycan /
associated sulfated glycosaminoglycan side chains. Fibrous proteins, such as collagen and
elastin, are of interest in part due to the strong roles these molecules generally play in
determining tissue biomechanical function. In particular, collagen contributes to the tensile
response of tissue, while elastin tends to dominate the elastic response. Hyaluronan impacts
tissue viscous response, and proteoglycans not only serve important regulatory functions by
sequestering bioactive molecules [42], but also contribute to tissue biomechanical properties
[25]. Therefore, quantitative study of these ECM molecules should yield insight into the
biomechanics of the LP. In addition, since tissue cellularity is altered in a number of
physiological and pathological processes, normal human LP total cellularity has been
examined.
Since the appropriate choice of animal model is integral to development of restoration
strategies applicable to humans, the LPs of several potential animal models have been
similarly studied and compared to the human LP. Dogs and pigs are currently two standard
animal models in vocal fold research, and hence these animals have been investigated.
Ferrets have also been analyzed in the present work for their potential as a small animal
model for LP implant studies. Although ferrets have not previously been used for vocal fold
research, their large airway relative to their size makes controlled surgical access to their
vocal folds feasible. In addition, ferrets appear to phonate more frequently and with greater
range than rabbits [43], a small animal that has been used in several recent vocal fold research
studies [10, 44].
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Chapters 3 and 4 present results from biochemical and immunohistochemical studies of LP
proteoglycans and LP collagen and fibronectin, respectively. Chapters 4 and 5 discuss
biochemical and histological results for elastin and hyaluronan and for tissue cellularity and
turnover, respectively.
Towards future in vitro studies of the interactions of LP cells with various implant materials,
methods for isolating vocal fold LP fibroblasts and appropriate media types for LP cell
growth and proliferation have been examined, as discussed in Appendix B.
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Chapter 2. Proteoglycans
2.1 Introduction
Proteoglycans (PGs) represent a large family of complex molecules composed of core
proteins to which sulfated glycosaminoglycan (sGAG) side chains, such as dermatan sulfate
(DS), chondroitin sulfate (CS), keratan sulfate (KS), or heparan sulfate (HS), are attached.
PGs are known to regulate cell adhesion, cell growth, and matrix formation [1], and to
influence tissue biomechanical properties [1, 2]. Both the absolute quantities and spatial
distributions of PGs types are important in the maintenance of appropriate tissue physiology
[3].
Histological studies on the PG/GAG content of the vocal fold lamina propria (LP) have been
published [4, 5] which have advanced the understanding of the normal presence of these
molecules. However, significant questions remain. Although the influence of PGs on LP
biomechanics has been discussed [5, 6], the degree of this impact is difficult to assess, since
the actual concentration of PGs in the LP is currently unknown. Pawlak et al.[5]
immunohistochemically analyzed the distributions of decorin, CS, KS, and a heparan sulfate
PG (HSPG) in normal human LP. A primary finding of this study was the intracellular
localization of CS. This is an unusual result which warrants further investigation, since many
other loose connective tissues contain this sGAG type throughout the ECM [7]. In addition,
the antibody used by Pawlak et al. [5] to examine the presence of HSPGs appears to recognize
only one molecule (Chemicon International, Technical Assistance) of the rich HSPG family.
Garrett et al.[4] histologically evaluated overall GAG distributions in dog and pig LP, but not
the distributions of specific PG/sGAG types. Thus, the quantity and distribution of PGs in
human and animal model vocal fold LPs merit further study.
The present work examines and compares the PG/sGAG content of normal human vocal fold
LP and that of dog, pig, and ferret. Specifically, LP PGs levels are quantitated indirectly by
measuring the concentration of total sGAG side chains, and immunohistochemical analyses
for specific PG/sGAG classes are presented for all four species.
2.2 Materials and methods
2.2.1 Tissue procurement
Eight human larynges were obtained within 24 hours post-mortem. The age, gender, source,
and method of preservation of these specimens are described in Table 2.1. All human tissue
included in this study appeared normal as assessed by a pathologist, and donors had no known
medical history of vocal fold surgery or chronic voice disorders. Human tissue was procured
with the approval and in accordance with the guidelines of the Massachusetts Institute of
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Technology (MIT) and Massachusetts Eye and Ear Infirmary (MEEI) committees on human
experimentation.
Six female beagle larynges (Marshall Farms, North Rose, NY) from 2-3 year old animals, six
pig larynges (Research 87, Inc) from 6-12 month old animals of both genders, and four adult
male ferret larynges (Marshall Farms, North Rose, NY) were recovered within 6 hours post-
mortem. All animal specimens included in this study had macroscopically and
microscopically normal vocal folds. For each animal laryngeal specimen, one hemi-larynx
was snap-frozen and stored at -80 0C for biochemical analysis and the second hemi-larynx was
placed into neutral buffered formalin at 40C for histochemical studies.
Epiglottis tissue from each species was processed histologically as a positive control tissue for
immunohistochemical studies. Pig hyaline cartilage was used as a biochemical assay control.
All animal tissue was procured with the approval and according to the guidelines of the MIT
animal care committee.
Table 2.1: Human specimen information*
Specimen Age Gender Source Preservation Analyses
SI 61 male MEEI surgical left vf: snap frozen biochemical
right vf: formalin fixed histological
S2 57 female Clinomics autopsy formalin fixed biochemical
histological
S3 49 male Clinomics autopsy formalin fixed histological
S4 48 male Clinomics autopsy formalin fixed biochemical
histological
S5 47 female Clinomics autopsy formalin fixed histological
S6 40 female MGH autopsy snap frozen biochemical
S7 55 female MGH autopsy snap frozen biochemical
S8 66 male MGH autopsy snap frozen biochemical
*MEEI, Massachusetts Eye and Ear Infirmary; MGH, Massachusetts General Hospital; Clinomics,
Clinomics Biosciences, Inc. Formalin-fixed human tissue was fixed in hemi-larynx form.
2.2.2 Tissue preparation for biochemical and histological analysis
Each snap-frozen animal or human (S 1, S6, S7, S8) hemi-larynx was briefly thawed in sterile
PBS, and the middle third of the vocal fold was excised for biochemical analysis. The
formalin-fixed human (S1, S2, S3, S4, S5) and animal hemi-larynges, after overnight fixation,
were transferred to 70% ethanol at 4'C for 16 hours, after which the middle third of each
vocal fold was retrieved. In human specimens S2 and S4, the anterior half of this middle third
was processed for histological analysis and the posterior half was further processed for
biochemical assays. Control samples were run to ensure that the formalin-fixation of the S2
and S4 portions reserved for biochemical analysis was not significantly altering measurements
for the biomolecules of interest.
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Histological specimens were paraffin embedded, and serial 5gm sections transverse to the
vocal fold free edge were cut. Epiglottis controls were exposed to the same histological
preparation conditions as the associated vocal fold tissue.
In tissue portions reserved for biochemistry, the muscular layer and superior and inferior
glandular regions were microdissected away. The remaining LP was then lyophilized and
stored at -80 0C until further analysis. At time of analysis, approximately 200gL of 50 gg/mL
filter-sterilized proteinase K (Worthington Biochemical, Lakewood, NJ) in 100mM sodium
acetate buffer, pH 7.0 was added to each biochemical sample per 1 mg tissue dry weight.
Digestion proceeded at 60'C for 24 hrs, with fresh proteinase K being added after 12 hrs and
again after 18 hrs. Hyaline cartilage controls were exposed to the same digestion conditions
and biochemical assays as the vocal fold LP specimens.
2.2.3 Biochemical analyses
2.2.3.1 Total protein quantification
As a measure of total protein in each sample digest, total amino acids, excluding tryptophan
and cysteins, were quantitated in triplicate by AAA Service Laboratory, Inc (Boring, Oregon).
The total amount of proteinase K added to each sample was approximately 30gg per 1mg dry
weight. Since protein appears to comprise approximately 75-85% of the LP dry weight
(unpublished observations), the contribution of proteinase K to total measured protein levels
will be considered negligible in comparison to the tissue contribution.
2.2.3.2 sGAG quantification
Total sGAG was measured using the Blyscan assay (Accurate Chemical and Scientific Corp.,
Westbury, NY), a modified dimethylmethylene blue assay. Each human, pig, and dog vocal
fold sample was measured in triplicate. Due to the small size of the ferret vocal fold, portions
of the ferret digests had to be pooled to bring the sGAG quantity into the range of the assay.
These pooled samples were measured in duplicate.
2.2.4 Immunohistochemical analyses
2.2.4.1 Antibodies
As previously mentioned, each PG contains a core protein and at least one GAG side chain.
Common side chain types include HS, DS, KS, and CS, with CS being further subdivided into
0-, 4-, and 6-sulfate forms. The type and length of sGAG side chains associated with a
particular PG core protein are often altered in tissue pathology, as are the levels of individual
core proteins [8]. Therefore, both the core proteins and side chains types in the LP are
important to characterizing its normal PG content. This study has analyzed the LP
distributions of decorin, biglycan, versican, and aggrecan core proteins and of chondroitin 6-
sulfate (C6S), chondroitin 4-sulfate (C4S), KS, and HS side chains. The antibodies, epitope
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retrieval methods, and dilutions used are listed in Table 2.2. Antibodies which require further
comment are described below.
Antibody clone 2B 1 (Calbiochem, LaJolla, CA) has been shown to bind PG-M/versican [9,
10], and clone 6B6 (Calbiochem, LaJolla, CA) recognizes decorin, but not biglycan [11].
Thus, throughout the remainder of this paper, the staining resulting from antibodies 2B 1 and
6B6 will be referred to as versican and decorin staining, respectively. For ferrets, the versican
antibody did not bind to the epiglottis positive control, implying the antibody to be non-
reactive with this species (data not shown). Similarly, the biglycan antibody was only applied
to human specimens, since initial tests with animal tissues seemed to indicate that antibody
binding was non-specific for biglycan in these species (data not shown).
Antibody clone 3G10 recognizes unsaturated uronic acid residues attached to HSPG core
proteins following heparitinase I digestion [9]. Antibody 3G10 has been shown to bind not
only cell-associated HSPGs, such as syndecans [9], but also matrix HSPGs, such as perlecan
[12]. The keratan sulfate antibody 5D4 (Calbiochem, LaJolla, CA) appears to recognize
highly sulfated corneal and skeletal KS PGs with high affinity and poorly sulfated or
unsulfated KS PGs with significantly lower affinity [13].
Table 2.2: Pre-treatment and antibody dilution factors
Antibody Clone Epitope Human Dog Pig Ferret
Retrieval Dilution Dilution Dilution Dilution
Aggrecan HAG5B 11 Trypsin 1:400 1:400 1:400 1:300
Dako Dako Dako Dako
Biglycan Courtesy of ABC 1:2400 N/A N/A N/A
Peter Roughley Sniper
ADi-4S 2B6 ACII 1:100 1:40 1:100 1:40
Dako Dako Dako Dako
ADi-6S 3B3 ABC 1:400 1:400 1:300 1:400
Dako Dako Dako Dako
Heparan sulfate F69-3G10 heparitinase I 1:900 1:1000 1:3000 1:1000
Dako Dako Dako Dako
Decorin 6B6 ABC 1:300 1:400 1:300 1:400
Dako Dako Dako Dako
Versican 2B1 ABC 1:800 1:400 1:300 N/A
Dako Dako Dako
Keratan sulfate 5D4 ABC 1:450 1:450 1:150 1:200
Dako Dako Dako Dako
The ADi-6S antibody recognizes C6S oligosaccharide stubs attached to PG core protein
following chondroitinase ABC (ABC) digestion of the tissue [7]. Similarly, antibody ADi-4S
binds stubs of DS and CS side chains bound to core proteins following ABC digestion [7]. In
this study, tissues receiving the ADi-4S antibody were treated with chondroitinase ACII
(ACII) rather than ABC. ACII cleaves CS-containing chains but not DS-containing chains,
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and, under these conditions, ADi-4S antibody staining emphasizes the distribution of C4S side
chains [7].
Several variants of aggrecan exist [1]. For example, the GI domain and KS side chains
associated with cartilaginous aggrecan appear to be largely absent in the aggrecan form
present in the tensioned regions of tendon [14]. Thus, the aggrecan antibody (Accurate
Chemical and Scientific Corp., Westbury, NY) used in this study was selected for the ability
to bind most aggrecan variants. Specifically, the aggrecan antibody used does not bind the
recombinant bacterial fragments corresponding to the GI or KS-bearing region of the
aggrecan core protein. Transmission electron microscopy (TEM) seems to indicate that the
antibody binds within the N-terminal portion of the chondroitin sulfate-attachment region
(Technical information, Accurate Chemical and Scientific Corp., Westbury, NY).
2.2.4.2 Immunohistochemical procedure
Unless otherwise stated, immunohistochemical steps took place in a humidified environment
at room temperature, and immunohistochemical reagents were purchased from Biocare
Medical (Walnut Creek, CA). Tissue sections were deparaffinized in xylene, taken to water
using graded ethanol baths, and then exposed to peroxidase block for 10 minutes.
Heparitinase I (Calbiochem, La Jolla, CA) was applied to the appropriate tissues at 0.02 U/mL
in 50 mM Tris acetate, 5mM calcium acetate pH 7.0 for 2 hours at 37'C. Tissues receiving
the ADi-4S antibody were treated with 0.1 U/mL ACII (Seikagaku America, Falmouth, MA)
in 50mM sodium acetate, 5mM calcium acetate pH 6.0 for lhr at 37'C. ABC (Seikagaku
America, Falmouth, MA) was applied at 0.1 U/mL dissolved in 100mM Tris, 10mM EDTA
buffer, pH 8.0 for 30 minutes at 37'C. For aggrecan antibody staining, tissues were digested
with 0.19% trypsin for 7 minutes at room temperature.
All tissues were subsequently treated with Avidin-Biotin block. After 10 minute incubation
with the blocking agent Terminator, tissue sections were lightly drained and the appropriate
antibody diluted either in Sniper or Dako antibody diluent (Dako Cytomation, Carpinteria,
CA), as specified in Table 2.2, was applied. Biglycan antibody was applied overnight at 40C,
whereas all other antibodies were applied for 1 hr at room temperature.
Following antibody application, goat anti-mouse IgG or goat anti-rabbit IgG secondary
antibody and streptavidin-HRP were applied sequentially for 10 minutes each. Antibody
binding was detected using chromagen DAB, after which slides were dipped in hematoxylin,
taken to xylene, and coverslipped.
Species-specific epiglottis sections served as positive controls for each antibody. Negative
control vocal fold sections for decorin, versican, biglycan, aggrecan, and KS involved
application of negative control serum in place of primary antibody following appropriate
enzymatic pretreatment. According to methodologies of Couchman et al.[7] and David et al.
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[9], negative controls for ADi-6S, ADi-4S, and 3G10 antibodies did not receive ABC, ACI,
or heparitinase I pretreatment, respectively, although primary antibody was applied.
2.2.5 Immunohistochemical image analysis
2.2.5.1 Image capture
An Axiolab microscope (Zeiss, Thornwood, NY) coupled to an Axiocam CCD camera (Zeiss,
Thornwood, NY) and to an Axiovision image analysis system was used for image recording.
For all slides, full spectrum 1030x1300 8-bit color images were recorded. Background
correction was performed prior to image capture by interactively referencing a blank field
using the Axiovision software.
2.2.5.2 Schematic development
A common LP microstructural organization appears to exist for all normal LP specimens of
given species, and recognition of this organization can facilitate intraspecies comparison of
LP staining patterns. Thus, schematics emphasizing repeatedly observed microstructural
subdivisions in the LP of each species have been developed and are displayed in Figure 2.1.
Figure 2.1: Schematics of repeatedly observed subdivisions within the vocal
fold LP by species. (A): human; (B): dog; (C): pig; (D): ferret.
To gain insight into the origin of the LP subdivisions depicted within these schematics,
examine the staining for C6S and versican in dog LP as shown in Figures 2.2a,c. Regions
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within these immunohistochemical images corresponding to the LP subdivisions present in
the dog LP schematic have been outlined using specific colors. Versican and C6S stained
specimens were selected to demonstrate dog LP subdivisions since each antibody
highlights/emphasizes different LP features. Although the exact placement and dimensions of
these dog LP subdivisions varies from specimen to specimen, as indicated in Figures 2.2g,h,
the subdivisions noted in the schematic have been observed in each dog LP examined in this
study. Figures 2.3, 2.4, and 2.5 illustrate the correspondence of subdivisions within the LP
schematics for human, pig, and ferret, respectively, to regions within actual specimen LPs.
For humans, the regions in Figures 2.3d-f outlined in red correspond to what laryngologists
have termed the superficial LP [15], whereas the blue-delineated regions correspond to the
deep LP. These designations of the LP region nearest the epithelium as the superficial LP, the
LP region nearest the muscle as deep LP, and the LP region in between these as the
intermediate LP, have been extended to the animal models (Figure 2.6) to facilitate qualitative
verbal descriptions of staining patterns.
It should be noted that the schematics illustrate gross LP morphology post-excision from the
larynx structure. Some alterations in the overall size and shape of each species' LP from its in
vivo state due to the excision of the midmembranous portion from its attachments post-
fixation should be anticipated.
2.2.5.3 Semi-quantitative image analysis
Consistent interspecies variations in LP staining patterns for specific molecules can give
insight into important LP microstructural or compositional differences across species.
However, interspecies comparison of antibody staining can be difficult, since the observed
intensity range for DAB staining varies with antibody, species, and with specimen within a
given species. Therefore, in seeking to compare LP antibody staining patterns across species,
relative staining intensity, rather than absolute intensity, should be examined. Relative
staining intensity within different LP subregions has been analyzed on a specimen-by-
specimen basis for each antibody as follows: LP regions within a specific specimen of
maximum staining intensity were assigned a 6 while regions of background staining intensity
were assigned a 1. Subregions with staining intensities between these extremes were assigned
numbers between 1 and 6, as appropriate, with an intermediate degree of staining being
assigned a 3-4. For a specific antibody, the numeric assignments for each LP region were
then averaged across all specimens of a given species and rounded to the nearest integer. The
resulting number was matched with a color code: 6=red, 5=yellow, 4=green, 3=light blue,
2=dark blue, l=purple. These colors were then applied to the appropriate subregions within
the LP schematics.
The average relative staining intensities for C6S and KS in the human LP were not assessed,
due to the relatively high variability among human specimens in staining patterns for these
antibodies. This variability made average relative intensity evaluations of unclear utility for
these molecules.
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Figure 2.2: Demonstration of the development of the dog LP schematic. (A): dog specimen stained for
C6S; (C): same dog specimen stained for versican; (E): dog LP schematic; (B, D, F): images (A, C, E),
respectively, with major dog LP features delineated with specific colors; (G): HS staining of a different
dog specimen; (H): image (G) with same major features delineated as in (B, D, F). Images (G, H) have
been included to demonstrate the variability in feature location and size among dog specimens.
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Figure 2.3: Demonstration of the development of the human LP schematic. (A): human specimen stained
for decorin; (B): human LP schematic; (D, E): images (A, B), respectively, with major human LP features
delineated with specific colors; (C): decorin staining of a different human specimen; (F): image (C) with
same major features delineated as in (D, E). Images (C, F) have been included to demonstrate the
variability in feature location and size among human specimens.
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Figure 2.4: Demonstration of the development of the pig LP schematic. (A): pig specimen stained for
decorin; (B): pig LP schematic; (D, E): images (A, B), respectively, with major pig LP features delineated
with specific colors; (C): HS staining of a different pig specimen; (F): image (C) with same major features
delineated as in (D, E). Images (C, F) have been included to demonstrate the variability in feature location
and size among pig specimens.
27
C
F
B r
E7
AA 
B 
C
D
4,
Figure 2.5: Demonstration of the development of the ferret LP schematic. (A): ferret specimen stained for
C6S; (B): same ferret specimen stained for HS; (C): ferret LP schematic; (D, E, F): images (A, B, C),
respectively, with major ferret LP features delineated with specific colors.
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Figure 2.6: Segmentation of dog, pig, and ferret LP into superficial, intermediate, and deep regions. The
region designated as superficial LP is outlined for each species in red, and the region designated as deep
LP is delineated in blue. (A): dog; (B): pig; (C): ferret.
2.2.6 Statistical analysis
Average LP sGAG levels for each animal species were compared to average human results
using an unpaired student t-test. Differences were considered statistically significant at a level
of p<0.05. Standard deviations (SDs) were calculated to include the SDs within and among
specimens of a given species. Since aliquots of the ferret specimens were pooled for the
sGAG assay, interspecimen variations in sGAG levels are not represented in the ferret SD,
although such variations are represented in human, dog, and pig sGAG SDs. Therefore, the
mean ferret sGAG concentration could not be strictly compared to that of humans by a student
t-test.
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2.3 Results
2.3.1 Biochemical results
Figure 2.7 shows total sGAG per mg tissue total protein for each species. Results are reported
as average + standard error of the mean. Dog and pig LP total sGAG concentrations were not
statistically different from that of human specimens (p>0.05), and total sGAG levels in ferret
LP appeared to be of the same order of magnitude as in human LP. No statistically significant
difference in human LP sGAG content with gender was noted (data not shown), although this
result is likely a reflection of the limited human specimen set.
For hyaline cartilage controls, the measured sGAG levels were within the range cited in
literature for normal hyaline cartilage [16] (data not shown).
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Figure 2.7: Total sGAG content by species. No statistically significant differences were found between the
mean sGAG for pig and dog and that of humans, p>0.05. Ferrets were not statistically compared to
humans, as discussed in Materials and Methods.
2.3.2 Immunohistochemical results
Figure 2.8 depicts representative images of vocal fold LP staining for versican, decorin, and
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Figure 2.8: Representative staining for versican, decorin, and C4S by species. (A, D, G): versican staining
in human, pig, and dog, respectively; (B, E, H, J): decorin staining in human, pig, dog, and ferret,
respectively; (C, F, I, K): C4S staining in human, pig, dog, and ferret, respectively. Scale bars =500 sm.
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2.9: Representative staining for C6S. (A, B, C): illustrate the range of C6S staining observed
human specimens; (D, E, F): C6S staining in dog, pig, and ferret, respectively. Scale bars = 500
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Figure 2.10: Representative staining for KS. (A, B, C): illustrate the range of KS staining observed among
human specimens; (D, E, F): KS staining in dog, pig, and ferret, respectively. Scale bars = 500 gm.
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Figure 2.11: Representative staining for biglycan and HS. (A): human biglycan staining; (B, C): human
HS staining; (D, E, F): HS staining in dog, pig, and ferret, respectively. Scale bars = 500 sm.
C4S for all four species. Figures 2.9 and 2.10 illustrate C6S and KS staining, respectively.
Three images of human LP C6S and KS staining have been included illustrate the variability
in staining observed among human specimens for these antibodies. Representative HS
staining in two human specimens and in the animal models is shown in Figure 2.11. Also
included in Figure 2.11 is a representative image of human LP biglycan staining. Aggrecan
staining could not be distinguished from background in any of the LP specimens, although
staining in the elastic cartilage epiglottis controls was intense (data not shown).
Semi-quantitative results for the average relative staining intensities of versican, decorin, and
C4S are displayed with respect to the species-specific LP schematics in Figure 2.12. Similar
analyses were carried out for C6S, KS, and HS staining, and the results are shown in Figure
2.13. Also contained in Figure 2.13 is the average relative intensity image for human LP
biglycan staining.
From Figure 2.12, it can be seen C4S staining was prevalent throughout the LP of each
species, although in humans, the staining was most intense in the deep LP. The distribution of
decorin in humans was primarily localized in the superficial and deep regions of the LP.
Versican staining, although also present in the superficial and deep layers, extended into the
human intermediate LP. The versican, decorin, and C4S distributions in pigs were very
similar, with staining being relatively intense in the deep and inferior LP and along the
epithelial-LP border. In dogs, the oblong subregion of the intermediate LP of relatively
intense versican staining corresponded to a region of low decorin and C4S staining. For
ferrets, decorin staining was most intense in the superficial region.
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C6S staining in humans showed several different patterns. In some specimens, staining for
this molecule was highest in the deep LP. In other specimens, C6S staining appeared to be
primarily localized to the superficial and intermediate layers. Some specimens showed
staining intermediate between the extremes represented by the above two cases.
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Figure 2.12: Semi-quantitative images for versican, decorin, and C4S staining. (A, D, G): average relative
versican staining in human, dog, and pig, respectively; (B, E, H, J): average relative decorin staining in
human, dog, pig, and ferret, respectively; (C, F, I, K): average relative C4S staining in human, dog, pig,
and ferret, respectively.
33
KS staining in humans also varied
very intense deep LP staining and
other specimens, the staining was
ferret, the oblong region of intense
A
D
G
from specimen to specimen, with some specimens showing
others showing minimal non-glandular related staining. In
intermediate between the above two extremes. In dog and
C6S staining in the intermediate LP corresponded to a
B
E
H
J
F
I
Low
Figure 2.13: Semi-quantitative images for C6S, KS, HS, and human biglycan staining. (A, D, G): average
relative C6S staining in dog, pig, and ferret respectively; (B, E, H): average relative KS staining in dog,
pig, ferret respectively; (C, F, I, K): average relative HS staining in dog, pig, ferret, and human
respectively. (J): average relative human biglycan staining.
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region of low observed KS staining. For pigs, KS staining was primarily superficially
oriented, whereas C6S seemed to follow a staining pattern similar to that with of versican.
Staining for HS in the human LP was relatively intense in the superior portion of the deep LP.
In some specimens, this staining extended throughout the deep LP. In dogs, HS staining
appeared to be primarily localized to the superficial LP, whereas in pigs HS staining was
distributed throughout the LP in the staining pattern similar to that of decorin. Ferret staining
for HS extended into the intermediate regions of the LP, although staining was highest near
the epithelial-LP boundary.
Human biglycan staining was highest in the superior region of the deep LP, with staining
extending throughout the deep LP in varying intensities depending on the specimen. Also,
biglycan staining was observed in the superior portion of the superficial LP in approximately
half of the human specimens examined.
2.4 Discussion
The present study has immunohistochemically analyzed the distribution of specific PG core
proteins and side chains in the midmembranous vocal fold LP of normal humans, dogs, pigs,
and ferrets. In addition, the PG levels in normal LP have been indirectly assessed by
quantifying levels of associated sGAG side chains relative to tissue total protein.
2.4.1 Biochemical results
The total sGAG concentration in the human LP was 0.015+0.002 mg per mg total protein,
with the total sGAG content in the three animal model LPs being similar to that of human.
The human LP total sGAG concentration is over an order of magnitude lower than that of
hyaline cartilage [16] and is similar to that of dermis [17]. These quantitative sGAG
measures, therefore, place the vocal fold LP in the context of other biochemically and
biomechanically well-characterized tissues and place bounds on the expected contribution of
PGs to LP biomechanical properties [18]. In addition, since PG/sGAG levels are frequently
altered in scar and disease states [3, 19], comparison of the total sGAG concentrations
presented here with those characteristic of abnormal LP states may yield insight into vocal
fold scarring and pathology and possible methods of restoring the normal tissue state.
2.4.2 Immunohistochemical results
Decorin staining in human specimens was intense in the superficial and deep LP, although
slightly less intense in the deep LP. These human decorin staining results correspond well
with those of Pawlak et al. [5] Among decorin's properties is the ability inhibit collagen
fibrillogenesis in vitro [20]. Previous histological work on the distribution of collagen in the
human LP has shown collagen levels to be, in general, markedly higher in the deep LP than in
the superficial LP [6, 21, 22]. In addition, the fibers in the human deep LP tend to be of
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greater thickness than those in the superficial LP [22]. The higher relative intensity of decorin
staining in the superficial LP in comparison to the relative intensity of collagen staining in this
region may in part account for these documented variations in collagen fiber density and
thickness within the human LP.
Biglycan staining in normal human LP appeared to be most intense in the deep LP and did not
show the same degree of superficial LP presence as that seen for decorin. The density of
biglycan relative to decorin appears to be altered in certain scar states [23], with the alteration
being dependent of scar type. Histological studies of rabbit vocal fold LP have shown decorin
to be reduced in LP scar[24], and a future concomitant study of biglycan alterations should
yield further insight into the nature of vocal fold scarring.
Versican, a large aggregating PG which binds to hyaluronan (HA) [1] and which is frequently
associated with elastic networks [25], was present in LP ECM of each species (Figure 2.8).
The highly hydrated versican-HA complex appears to inhibit cell-matrix interactions [26], to
play a role in dissipation of impact and compressive stresses [27], and to affect tissue turgor
[27]. In addition, versican has been implicated in the formation of interstitial lung edema[28]
and may similarly contribute to human Reinke's edema. Like versican, aggrecan is a large
aggregating PG which can associate with HA to form highly hydrated complexes and is a
characteristic PG in cartilage and fibrocartilage. The results of the present study seem to
indicate that aggrecan is not one of the primary PGs in the midmembranous LP (data not
shown).
KS staining varied significantly among human specimens, with the consistent KS staining of
the vocal ligament noted by Pawlak et al. [5] not being observed in this study. Similar
interspecimen variations in KS staining were not noted in the animal models. The reasons for
the discrepancy with the KS results of Pawlak et al.[5] are at present unclear, since the same
antibody was used in both studies. However, the interspecimen variations in human KS
staining observed in the present study may be in part attributable to the properties of the 5D4
antibody used to detect KS PG. As previously mentioned, poorly sulfated or unsulfated KS
PGs show low affinity for this antibody. Therefore, the human variability in 5D4 staining
may reflect interspecimen differences in KS sulfation levels rather than differences in total KS
PG present.
Although the KS PG fibromodulin has been identified in human [29] and rabbit [24] vocal
LPs, it is not clear if this is the only or most prevalent KS PG in the LP. Both lumican and
fibromodulin are among the more abundant KS PGs in non-corneal,-scleral, and -cartilaginous
connective tissues, and both are involved in regulation of collagen fibrillogenesis and
maintenance of tissue tensile strength [30]. Further analysis would be required to determine
the identities of the KS PGs in the vocal fold LP. If lumican does, however, prove to be a
constituent of the LP, its presence may not be represented in the 5D4 KS staining patterns
observed in this study, since lumican in non-corneal tissues is generally present in poorly
sulfated or non-sulfated forms [30].
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As with KS, marked interspecimen variations in C6S staining patterns were noted in the
human LP, although similar interspecimen variations were not noted for the animal models.
Possible physiological grounds for the observed variations in C6S staining among human
specimens are at present unclear. In addition, linking the observed C6S and C4S staining
patterns with specific PG core proteins is complex. For example, decorin, biglycan, and
versican core proteins are known to have CS and/or DS side chains. The relative fractions of
these side chains as well as the sulfation of the CS chains attached to the decorin, biglycan,
and versican core proteins varies with tissue type and region [31] and with health [8]. It is
likely that all three of these core proteins contribute to the observed C4S and C6S staining
patterns.
The results for human versican, C6S, and C4S appear to revise previously published results
on the PG composition of the human vocal folds [5]. Although the presence of versican was
hypothesized by Pawlak et al. [5] based on observed CS staining, this molecule and other
C6S- and C4S-bearing PGs were believed to be present primarily intracellularly. These
deductions were based on observed LP staining with ADi-6S antibody [5], the same antibody
used in the present work to detect C6S. The distinction between the present results and those
of Pawlak et al.[5] likely results from differences in tissue pretreatment prior to antibody ADi-
6S application. Pawlak et al. [5] appears to have used the ADi-6S antibody without
chondroitinase pretreatment of the tissue. However, due to the nature of this antibody, such
enzymatic pretreatment is necessary for evaluation of C6S bearing PG in the ECM [7].
HSPG was observed to be present in the LP ECM, in addition to cell- and basement -
membranes (Figure 2.11). The association of HSPG staining with the superior portion of the
human LP vocal ligament was particularly striking. The presence of HSPG separate from
cell- or basement-membranes in the LP is in contrast to the results of Pawlak et al.[5], where
LP HSPG was reported to be intracellularly or basement membrane localized. This
discrepancy likely results from the antibodies selected to detect HSPG. The antibody used in
the present study recognizes a range of cell-associated and matrix-associated HSPG, whereas
the antibody used by Pawlak et al.[5] appears to recognize a single HSPG type. Matrix
HSPGs are generally most abundant in basement membranes, regions that bear high shear
stresses, and certain HSPGs have been found to be critical to maintaining basement
membrane integrity in response to stress [32]. Thus, the presence of HSPG in the LP ECM
may be a reflection of the shear stresses sustained by this tissue.
Among the biological functions of many PG types is the ability to bind growth factors. For
example, decorin, biglycan, and fibromodulin, are known to modulate TGF- activity [32].
Certain matrix HSPGs appear to modulate bFGF activity[l], and highly sulfated HS has been
shown to potentiate the activity of TGF- 1 [32]. bFGF has been shown to inhibit
elastogenesis in rat lung fibroblasts [33], whereas TGF- 1 increases elastin and collagen
synthesis in dermal fibroblasts [34] and lysyl oxidase activity [35] in lung fibroblasts. Thus,
the observed spatial variations in PG presence may imply that a region-specific balance of
various PG groups is critical to the development /maintenance of the layered structure
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characteristic of normal adult human LP and of the subdivisions characteristic of each animal
LP.
To the author's knowledge, this work presents the first quantitative measures of the total
sGAG content of human and animal model vocal fold LP. It also clarifies and expands upon
previous studies of specific PG/sGAG types present in the human LP. In particular, versican,
C6S, C4S, and HSPG, molecules previously believed to be intracellularly or basement
membrane-localized, have been identified in the LP ECM. An in depth study of dog, pig, and
ferret LP PG/sGAG content has also been conducted, and significant interspecies differences
in the distributions of specific PG/sGAG types have been noted.
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Chapter 3. Collagen and Fibronectin Glycoproteins
3.1 Introduction
Recognition of the impact of the glycoprotein collagen on normal vocal fold lamina propria
(LP) function has led to a number of histological studies of collagen in the human LP. The
distribution of collagen fibers throughout the human LP has been well studied with respect to
age and gender [1-6], and electron microscopy has been used to assess LP collagen fiber
thickness and ultrastructure [3, 5]. Similarly, the collagen distribution of several potential
animals model LPs has been histologically evaluated and qualitatively compared to that of
human LP [7, 8].
Despite these advances, significant unknowns remain. For example, concentration of
collagen in the vocal fold LP has not yet been quantified. Moreover, a number of second-
order biochemical features which can have significant impact on tissue health and function,
such as the collagen types present in the LP and their distributions, are currently not well-
characterized, particularly in potential animal models.
The glycoprotein fibronectin has been shown to be present throughout the human LP in
various disease states [9-11]. In dogs and rabbits, the staining for fibronectin in the LP has
been shown to increase with scarring [12, 13]. Due to marked alterations in fibronectin
concentration associated with LP scar, it is desirable that the normal LP fibronectin presence
in human and in potential animal models be understood.
This study expands upon previous work on the collagen and fibronectin content of the normal
human vocal fold LP. Hydroxyproline analysis has been used to quantify total collagen in
human LP. Since human vocal fold scarring is generally limited to the superficial LP [14],
quantitative histology has been used to calculate the percentage collagen in specific LP
regions. In addition, the distributions of several collagen types and of fibronectin in normal
human LP have been histochemically evaluated. Similar biochemical and histological
analyses have been carried out on dogs, pigs, and ferrets towards identifying an appropriate
animal model for implant evaluation.
3.2 Materials and methods
3.2.1 Tissue samples and preparation
The tissue specimens and controls used in this study and their preparation for biochemical or
histological assays were the same as in Chapter 2.
41
3.2.2 Biochemical analyses
3.2.2.1 Tissue digestion and total protein quantitation
Specimens allocated for biochemical analyses were digested with proteinase K (Worthington
Biochemical, Lakewood, NJ) for 24 hrs at 60'C as described in Chapter 2. Total protein in
the sample digests was quantitated in triplicate via amino acid analysis by AAA Service
Laboratory, Inc. (Boring, OR), as detailed in Chapter 2.
3.2.2.2 Total collagen quantitation
Specimen digest hydroxyproline levels were quantitated in duplicate by the Texas A&M
University Protein Chemistry Laboratory (College Station, TX) and independently in
duplicate/triplicate runs by AAA Service Laboratory, Inc (Boring, OR). These two amino
acid analysis services use different detection techniques, one based on pre-column
derivatization and the other based on post-column derivatization [15]. Both methods were
used to quantitate the hydroxyproline content of digested samples to minimize the possibility
that buffer or sample contaminants were significantly altering the measured amino acid
values. Milligrams total collagen in the LP specimens were calculated from milligrams
hydroxyproline by dividing by 0.13, a conversion factor that assumes the dominant collagen
type to be collagen type I [16]. For hyaline cartilage controls, a conversion factor of 0.12,
which assumes collagen type II to be the primary collagen type [16], was used.
3.2.3 Histochemical analyses
3.2.3.1 Immunohistochemical staining
The antibodies, epitope retrieval methods, and dilutions used in the present study are noted in
Table 3.1. Unless otherwise stated, immunohistochemical steps took place in a humidified
environment at room temperature, and immunohistochemical reagents were purchased from
Biocare Medical (Walnut Creek, CA).
Tissue sections exposed to only enzyme-based epitope retrieval were deparaffinized in
xylene, taken to water using graded ethanol baths, and then blocked with peroxidase for 10
minutes. if pretreatment with chondroitinase ABC (ABC) was indicated, the tissue sections
were then digested with 0.1 U/mL ABC (Seikagaku America, Falmouth, MA) dissolved in
100mM Tris 10mM EDTA, pH 8.0 for 30 minutes at 37'C. When appropriate, 0.1% pepsin
(LabVision, Fremont, CA) or 0.19% trypsin was applied for 7 minutes.
For tissues receiving collagen type IV antibody, combining heat-induced epitope retrieval
with enzymatic treatment appeared to be more effective for antigen unmasking than either
method used alone (data not shown). Since combined heat-induced/enzymatic epitope
retrieval strategies tend to be more prone to nonspecific staining, particular attention was paid
to the collagen IV control tissues to ensure staining specificity. For these tissues,
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deparaffinization, peroxidase blocking, and heat-induced epitope retrieval were carried out
simultaneously by exposing slides to Reveal for 20 minutes at 95'C in a temperature
controlled pressure-cooker (Biocare Medical, Walnut
subsequently applied for 3 minutes.
Creek, CA). 0.1% pronase was
Table 3.1: Pre-treatment and antibody dilution factors
Antibody Clone Epitope Human Dog Pig Ferret
Retrieval Dilution Dilution Dilution Dilution
Collagen type I N/A ABC 1:800 1:300 1:1200 1:3000
Pepsin Sniper Sniper Sniper Sniper
Collagen type II 6B3 Pepsin 1:200 1:200 1:200 1:200
Dako Dako Dako Dako
Collagen type III N/A ABC 1:800 1:500 1:4000 1:3000
Pepsin Sniper Sniper Sniper Sniper
Collagen type IV CIV-22 Reveal 1:150 1:150 1:150 1:300
Pronase Dako Dako Dako Dako
Fibronectin IST-3 Pepsin 1:150 1:150 1:150 1:300
Dako Dako Dako Dako
All slides were treated
steps. After incubation
with Avidin-Biotin block following the appropriate epitope retrieval
with blocking agent Terminator for 10 minutes, tissue sections were
lightly drained, and the appropriate antibody, diluted either in Sniper or general antibody
diluent (Dako Cytomation, Carpinteria, CA), was applied. Collagen type II antibody was
applied at room temperature for 1 hr, whereas all other antibodies were applied overnight at
40C.
Following primary antibody application, goat anti-mouse or goat anti-rabbit IgG secondary
antibody and streptavidin-HRP were applied sequentially for 10 minutes each. Bound
antibody was detected using chromagen DAB.
Epiglottis sections served as positive controls for each antibody. Negative control vocal fold
sections involved application of negative control serum or antibody diluent in place of
primary antibody following appropriate enzymatic pretreatment.
3.2.3.2 Picrosirius staining
To examine the distribution and orientation of collagen in the LP, tissue sections were
picrosirius stained. Briefly, after being washed in tap water (10 minutes) and in distilled
water (2 minutes twice), tissues were treated with 0.2% phosphomolybdic acid for 5 minutes
and then with 0.1% Sirius Red in saturated aqueous picric acid for 90 minutes. The sections
were rinsed in tap water for 3 minutes, treated with 0.0 IN HCl for 2 minutes, dehydrated, and
coverslipped.
43
3.2.3.2.1 Bright field information
When picrosirius stained tissues are viewed in bright field, fibrillar collagens, collagen type
IV, and amyloid, if present, appear red. Amyloid is a protein that is primarily deposited in
connective tissues under pathological conditions. In tissues where amyloid presence can be
considered negligible in comparison to that of collagen, such as in many normal connective
tissues, the extent of Sirius Red dye binding can be used to quantitate total collagen levels in
tissue sections [17, 18]. Bright-field picrosirius staining will thus be used for quantitative
histological assessment of LP total collagen following the method of Kratky et al. [18].
3.2.3.2.2 Cross-polarized information
When viewed under cross-polarized light, picrosirius staining is specific for fibrillar collagen.
In early papers on picrosirius staining, it was proposed that collagen type could be determined
from the fiber color observed under cross-polarization conditions. Specifically, yellow or
orange/red fibers were believed to be collagen type I, green fibers to be collagen type III, and
blue to yellow fibers to be collagen type II [19, 20]. It is now understood that observed fiber
color under cross-polarization depends on a number of factors other than collagen type,
including: 1.) its degree of crosslinking, 2.) its orientation relative to the cut plane, 3.) and, if
using cross-polarized light rather than circularly polarized light, the fiber orientation relative
to the initial polarizer. As an example of point 2, if a collagen fiber is oriented such that its
axis is transverse to the cut plane of the tissue section, this fiber will generally not be visible
under cross-polarization [21]. Hence, in this study, the birefringence property of picrosirius
staining will be used primarily to study changes in collagen orientation within the LP rather
than to identify collagen type.
3.2.4 Histochemical image analysis
3.2.4.1 Image Capture
An Axiolab microscope (Zeiss, Thornwood, NY) coupled to an Axiocam CCD camera (Zeiss,
Thornwood, NY) and to an Axiovision image analysis system was used for image recording.
All stained tissue sections were imaged as full-spectrum 1030x1300 8-bit color images.
Background correction was performed prior to image capture by interactively referencing a
blank field using the Axiovision software.
For picrosirius stained tissues, further images were taken under controlled conditions to allow
for subsequent extraction of concentration information, according to the method of Kratky et
al. [18]. Specifically, a l0nm bandpass interference filter (Edmund Industrial Optics,
Barrington, NJ) centered at 540nm was placed between the microscope light source and slide
stage during image capture. 1030x1300 8-bit grayscale images were recorded.
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3.2.4.2 Semi-quantitative image analysis
To facilitate interspecies comparison of staining patterns, average relative staining intensity
for bright-field picrosirius and fibronectin staining has been semi-quantitated on a specimen-
by-specimen basis using the methodology described in Chapter 2.
3.2.4.3 Quantitative image analysis
Scarring is often localized to the superficial LP [14], and therefore a quantitative comparison
of the composition of the superficial LP relative to the overall LP would be useful in
developing/evaluating scar restoration strategies.
To have a reproducible means of separating the LP into layers, MATLAB was used to
segment each LP image into three subregions, subject to the following constraints: (1) the
muscle underlying the LP formed part of the boundary for only one subregion, (2) the
epithelium overlying the LP formed part of the boundary for only one subregion, (3) no
subregion bordered both epithelium and muscle, and (4) each subregion constituted
approximately 33% of the total LP cross-sectional area. The subregion bordering the
epithelium and the subregion bordering the muscle will be referred to as the superficial third
(ST) and the deep third (DT), respectively. The remaining subregion will be called the
intermediate third (IT).
The overlap of these MATLAB defined ST, IT, and DT subregions with the traditional
superficial, intermediate, and deep layers of the human LP, although strong, is not exact. The
MATLAB algorithm was used over visual segmentation because it allowed reproducible and
objective separation of the LP into subregions with a uniform methodology for all species.
In quantitating the relative antigen concentration within a given tissue region, the concepts of
optical density (OD) and integrated optical density (IOD) were used. The negative logarithm
of the grayscale value of a pixel divided by the average grayscale value of the background can
be defined as the OD of that pixel. The IOD of a region can be defined as the sum of optical
density elements in that region. Assuming staining to be stoichiometric to antigen presence,
microscope source wavelength to be narrow bandpass, and the microscope and associated
camera to be operating linearly, the IOD of a region can be assumed to be linearly related to
the mass of the antigen in that same region [18, 22].
Once subregions had been defined, IODs for the overall LP and for each LP subregion were
calculated for each picrosirius stained specimen. Since regional IODs and overall lamina
propria IODs (LP-IODs) varied among specimens based on differences in staining intensity
and in LP dimensions, regional IOD values were normalized by dividing by the overall LP-
IOD for that specimen.
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3.2.5 Statistical analysis
The total collagen concentration in each animal model LP was compared to that of human LP
using an unpaired student t-test. Differences were considered statistically significant at a level
of p<0.05. Human total collagen biochemical results were broken down further and
statistically analyzed with respect to gender (3 male and 3 female specimens).
3.3 Results
3.3.1 Biochemical results
Figure 3.1 illustrates the average LP collagen content per milligram tissue total protein by
species. Figure 3.2 presents human LP collagen concentrations analyzed with respect to
gender. Results are reported as average + standard error of the mean. Whereas average
collagen levels in dog and human LP were statistically similar (p>0.05), the mean collagen
content of ferret and pig LPs were found to be significantly different from that of human LP
(pig: p<0.016, ferret: p<0.01 1). In addition, a statistically significant difference was observed
between male and female human LP collagen levels (p<0.024).
For hyaline cartilage controls, the mean collagen concentration was within the range cited in
literature for normal hyaline cartilage [23] (data not shown).
3.3.2 Histochemical results
Figure 3.3 displays representative bright field picrosirius images and corresponding cross-
polarized images. Alongside these full-spectrum images, the narrow bandpass OD images
used in regional collagen quantitation are displayed in pseudocolor to enhance visualization.
The MATLAB-defined ST and DT subregions are outlined in yellow in each pseudocolored
OD image. Figure 3.4 depicts representative collagen type I and collagen type III staining
across species. Figures 3.5 and 3.6 illustrate representative collagen type IV staining and
representative fibronectin staining, respectively. Semi-quantitative staining results for total
collagen and fibronectin are displayed with respect to the species-specific schematics in
Figure 3.7.
In describing the histochemical results, the segmentation of the LP of each species into
superficial, intermediate, and deep regions developed in Chapter 2 will be used. As can be
seen from Figure 3.5, collagen type IV was primarily found in association with basement
membranes. However, collagen type IV also appeared to be present in non-basement
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Figure 3.1: Total collagen content by species. Pig and ferret collagen levels were found to be significantly
different from human collagen levels, (pig: p<0.016, ferret: p<0.011).
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Figure 3.2: Total collagen content by gender. Specimen numbers: males: 3;
levels in the males were significantly different from that in females: (p<0.024 ).
females: 3. Mean collagen
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membrane associated regions of the LP in each species. In dogs and ferrets, collagen type IV
staining was extensive throughout the superficial region, and in ferrets staining was also
diffuse in the intermediate region. In humans, collagen type IV staining was present in the
intermediate and deep LP and tended to be more prominent in the superior regions of these
layers than in the inferior regions. Collagen type IV staining was detected throughout the pig
LP, although staining tended to be most intense in the superficial and deep LP.
From Figures 3.3 and 3.7, it can be seen that the LP total collagen distribution, as indicated by
the bright-field picrosirius stain, was unique for each animal. In dogs and ferrets, collagen
staining appeared to be more superficially localized relative to the collagen distributions in
humans and pigs.
For pigs, humans, and ferrets, the bright-field LP picrosirius images corresponded well with
the cross-polarized images in terms of implied collagen intensity distributions, although for
humans the collagen presence in the superficial LP indicated by cross-polarization was
occasionally lower than expected based on the bright field images. In dogs, however, bright
field and cross-polarized images differed markedly in the degree collagen presence indicated
in an extended strip of tissue within the ST (see Figure 3.3d-e). Upon further examination, it
appeared that many collagen fiber axes in this region were oriented perpendicular to the cut
plane, implying that they would have minimal visibility under cross-polarization. In addition,
the superior portion of this strip displayed relatively intense staining for collagen type IV, a
collagen type observable in bright field but not generally visible under cross-polarization.
Thus, the effects of fibrillar collagen orientation and collagen type IV presence in this region
likely combine to account for the discrepancy between dog bright field and cross-polarized
picrosirius images.
Figure 3.4 indicates that the staining patterns for collagen types I and III are correlated in
humans, pigs, and ferrets, although in humans, collagen type III appears to have a greater
percentage of its fibers in the intermediate LP than does collagen type I. In dogs, collagen
type III staining tended to decrease from surrounding regions in the oblong subregion of the
intermediate region. However, collagen type I staining was not similarly altered in this
subregion compared to surrounding tissue. Staining for collagen type II was not detected in
the LP of any of the species studied, although staining for collagen type II in the positive
control sections was intense (data not shown).
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Figure 3.3: Representative picrosirius stained sections viewed under bright field and cross-polarization.
(A, D, G, J): bright-field picrosirius staining in human, dog, pig, and ferret LP, respectively; (B, E, H, K):
cross-polarized picrosirius images for human, dog, pig, and ferret, respectively. (C, F, I, L):
pseudocolored OD images used in collagen quantification in human, dog, pig, and ferret, respectively.
The regions outlined in yellow in (C, F, I, L) indicate the ST and DT regions. Scale bars =500 pm.
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Figure 3.4: Representative collagen type I and collagen type II staining by species. (A, C, E, G): collagen
type I staining in human, dog, pig, and ferret LP, respectively; (B, D, F, H): collagen type III staining in
human, dog, pig, and ferret, respectively. Scale bars =500 m.
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Figure 3.5: Representative collagen type IV staining by species. (A, C, E, G):
human, dog, pig, and ferret LP, respectively. Scale bars=500 pm. (B, D, F, H):
of A, B, C, D, respectively, to show fine detail. Scale bars =250 m.
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Figure 3.6: Representative fibronectin staining by species. (A, B, C, D): fibronectin
staining in human, dog, pig, and ferret, respectively. Scale bars =500 pm.
Fibronectin staining in humans and pigs (Figure 3.6) appeared to closely follow the staining
for total collagen, although fibronectin staining in humans tended to be more superficially
oriented than the corresponding staining for collagen. In ferrets, fibronectin staining appeared
to be most concentrated at the epithelial-LP border and in the deep third of the LP. Dog
fibronectin staining was high along the inferior epithelial-LP border and relatively low in the
oblong subregion of the intermediate LP.
Figure 3.8 depicts the average fractional IODs for total collagen in the ST, IT, and DT
subregions of each species. The corresponding average fractional areas associated with each
subregion are indicated in the figure legend. For dogs and ferrets, the quantitative trends in
collagen distribution were essentially mirror-images of that seen in humans. In pigs, collagen
had a greater superficial presence than in humans. In contrast to total collagen levels, no
significant differences in the distribution of collagen in the ST, IT, and DT regions of the
human LP were noted with respect to gender (data not shown), although this result may
reflect limited specimen number.
The quantitative IOD results can be used to calculate the concentration of collagen in various
LP subregions. For example, for humans, the fraction of collagen present in the ST according
to IOD calculations is approximately 0.19+0.03, and the overall LP average collagen
concentration is approximately 0.43+0.03 mg per mg total protein. The fractional area
represented by the ST is about 0.31 +0.01. Thus, assuming fractional protein in a region to be
proportional to the fractional area of that region, the average collagen concentration in the
human ST is approximately 0.26±0.05 mg per mg ST total protein.
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Figure 3.7: Semi-quantitative images for total collagen and fibronectin staining. (A, C, E, G): average
relative total collagen staining in human, dog, and pig, and ferret, respectively; (B, D, F, H): average
relative fibronectin staining in human, dog, pig, and ferret, respectively.
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Figure 3.8: Fraction of overall collagen IOD by region. The average fractional areas calculated for each
species by region: Human: (ST: 0.307±0.009, IT: 0.360+0.005, DT: 0.333±0.005); dog: (ST: 0.365+0.019,
IT: 0.315+0.008, DLP: 0.320±0.019); pig: (ST: 0.294+0.012, IT: 0.382±0.003, 0.324±0.009); ferret: (ST:
0.362±0.019, IT: 0.354+0.004,-0.284±0.019).
3.4 Discussion
3.4.1 Biochemical results
LP total collagen levels varied from a low of approximately 30+3% of tissue total protein in
ferrets to a high of approximately 53±2% in pigs. Humans were intermediate in this range
with total collagen being approximately 43+3% of LP total protein. These values are in
contrast to skin and hyaline cartilage where collagen constitutes approximately 70% [24] and
80% [23], respectively, of tissue total protein. Thus, the collagen concentration in the vocal
fold LP is notably lower than that in dermis or hyaline cartilage, a result which has bearing on
vocal fold LP biomechanical properties relative to these tissues.
Interestingly, a statistically significant difference between male and female human LP total
collagen content was noted, with collagen levels being approximately 49+/-1% for males and
38+/-1% for females. This observed gender difference in collagen concentration supports the
histological findings of Hammond et al. [1], in which the observed intensity of human vocal
fold LP picric acid staining appeared to be significantly greater in males than in females.
Gender differences in collagen and other matrix components are of interest, since they may
yield insight into the greater vulnerability of females to LP scarring. However, the collagen
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results presented in this paper are based on a relatively small sample set, and more extensive
studies are required before broad statements concerning gender differences in human LP
collagen content can be made.
3.4.2 Histochemical results
The spatial distributions of total collagen observed in human, dog, and pig LPs in the present
study, appear to closely match the collagen staining noted in previous studies for these species
[1, 2, 7, 8]. Comparing semi-quantitative results for collagen distribution with those found for
decorin in Chapter 2, it can be seen that decorin staining is more superficially localized in the
human LP than is the total collagen staining. This observation, as noted in Chapter 2, may be
in part related to the documented changes in collagen fiber diameter and density as one
progresses from the superficial to the deep LP [1, 3, 4].
When comparing the intensity distribution in cross-polarized picrosirius stained images with
that of their bright-field counterparts, changes in collagen orientation within the LP can
became visible. Collagen fiber orientation and spatial variations in this orientation can have
significant impact on the biomechanical properties of a tissue. In addition, collagen fiber
orientation and density tends to be altered in scar tissue, and hence understanding normal
spatial variations in LP collagen fiber orientation is desirable. Differences between the bright
field and cross-polarized picrosirius images were most striking for dogs in an extended strip
of ST tissue. The physiological/functional reasons for this marked regional alteration in dog
LP collagen fiber orientation are at present unclear.
According to antibody staining studies, collagen types I and III appear to be the primary
collagen types present in the midmembranous vocal fold LP in all species analyzed. Collagen
type II does not seem to be a major collagen type in the midmembranous portion of the LP.
The dominance of collagen types I and III appears to correlate with high frequency shearing,
compressive, and tensile forces that this tissue must withstand while maintaining resilience
[25, 26].
As expected, collagen type IV has been found in association with the basement membrane
zone and blood and lymphatic vessels in the LP. What is interesting about the observed
collagen type IV staining is its apparent presence in non-basement membrane associated
regions of the LP, with staining extending into the deeper portions of human and pig LPs. In
dogs and ferrets, the collagen type IV distribution was still extensive but tended to be more
superficially limited. Collagen type IV is generally found in tissue regions that are required to
withstand high shear stresses [27]. Thus, the presence of collagen type IV in the LP ECM
may be a reflection of the shear stresses sustained by this tissue. The collagen type IV results
also appear to support the relatively extensive LP staining for heparan sulfate described in
Chapter 2, since collagen type IV and matrix heparan sulfate proteoglycans are frequently co-
localized [28].
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Fibronectin is a glycoprotein found in interstitial matrix and plasma, which plays a critical
role in cell adhesion, migration, and proliferation and in wound repair [29]. Since fibronectin
concentration and distribution appears to be altered in LP scar [13], understanding normal
fibronectin distribution is desirable.
The present study is, to the author's knowledge, the first to provide quantitative measures for
the total collagen concentration in the human vocal fold LP and in three animal model LPs.
Since human vocal fold scarring is generally limited to the superficial LP, quantitative
histology has been used to assess the collagen levels this LP subregion. Additionally, the
presence and distributions of specific collagen types and fibronectin have been
immunohistochemically investigated in the normal LP for all four species.
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Chapter 4. Elastin and Hyaluronan
4.1 Introduction
The contribution of elastin to vocal fold lamina propria (LP) biomechanical properties has
long been recognized [1, 2], and recently, the impact of hyaluronan (HA) on LP
viscoelasticity has begun to be examined [3]. Several histological studies have investigated
the presence of elastin [1, 4, 5] and HA [6] in the human LP, and electron microscopy studies
have examined spatial changes in LP elastic fiber thickness and orientation [7-9].
Additionally, the distributions of elastin [10, 11] and total GAG [10] in the LPs of several
animal models have been histologically evaluated and qualitatively compared to those of
human. Although these studies have significantly advanced the understanding of LP
biochemical composition, significant unknowns remain. For example, the concentrations of
HA and elastin in normal LP have not yet been evaluated for humans or potential animal
models.
This study focuses on characterizing vocal fold LP elastin and HA content. Specifically,
quantitative measures of desmosine, an amino acid found only in cross-linked elastin
molecules, and of HA in the human vocal fold LP are presented. Since vocal fold scarring is
generally limited to the more superficial portions of the LP [12], quantitative histology has
been used to calculate the percentage of elastin or HA in specific regions of the vocal fold LP.
In addition, the presence of fibrillin- 1 in relation to elastin has been histochemically evaluated
to gain insight into tensile stress distribution within the LP. Similar analyses have been
carried out on dog, pig, and ferret LPs towards defining an appropriate animal model for
implant based restoration studies.
4.2 Materials and methods
4.2.1 Tissue samples and preparation
The tissue specimens and controls used in this study and their preparation for biochemical or
histological assays were the same as in Chapter 2.
4.2.2 Biochemical analyses
4.2.2.1 Tissue digestion and total protein quantitation
Specimens allocated for biochemical analyses were digested with proteinase K (Worthington
Biochemical, Lakewood, NJ) for 24 hrs at 60'C as described in Chapter 2. Total protein in
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the sample digests was quantitated in triplicate via amino acid analysis by AAA Service
Laboratory, Inc. (Boring, OR), as described in Chapter 2.
4.2.2.2 Desmosine quantitation
Elastin levels were examined indirectly by quantitating desmosine according to the
radioimmunoassay protocol described in King et al. [13] Human, dog, and pig digests were
measured in triplicate, whereas ferret digests were measured in duplicate due to limited
sample. Since desmosine comprises a relatively constant portion of elastin residues in any
particular species, desmosine can be used as an indicator of tissue elastin content [14].
Although the desmosine content of elastin extracted from various human, dog, and pig tissues
has been quantified [14], the desmosine content of ferret elastin has not been investigated.
For this reason, measured LP desmosine concentrations, rather than converted elastin values,
will be reported for all species.
4.2.2.3 Hyaluronan quantitation
HA in each human, pig, and dog digest was measured in triplicate and each ferret digest in
duplicate using a HA ELISA kit (Echelon Biosciences, Salt Lake City, UT). The post-
mortem age of the human specimens prior to preservation was on average about 14 hours
greater than that of the animal specimens. Significant extracellular matrix degradation could
have occurred during this time period. Since the HA ELISA assay is sensitive to HA
degradation, the HA levels presented for humans should be regarded as first-order measures.
4.2.3 Histochemical analyses
4.2.3.1 Hyaluronan staining
To detect HA histologically, serial sections from each LP histology specimen were used. One
section from each specimen was exposed to 100 TRU/mL of hyaluronidase from
Streptomyces hyaluronticus (EMD Biosciences) for 24 hours at 37'C in a buffer containing
100mM sodium formate, 0.1mg/mL BSA, 0.15M NaCl, 0.1% Triton, pH 3.7, with fresh
hyaluronidase being added after 12 hours. The remaining section from each specimen was
exposed to sodium formate buffer containing no hyaluronidase for 24 hours at 37'C, with
fresh sodium formate buffer being added after the first 12 hours. The tissue sections were
then rinsed in deionized water and stained with alcian blue pH 2.5 according to standard
protocols [15], although no counterstain was used.
4.2.3.2 Immunohistochemical staining
The antibodies, epitope retrieval methods, and antibody dilutions used in the present study are
noted in Table 4.1. Unless otherwise stated, immunohistochemical steps took place in a
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humidified environment at room temperature, and immunohistochemical reagents were
purchased from Biocare Medical (Walnut Creek, CA).
Tissue sections were deparaffinized in xylene, taken to water using graded ethanol baths, and
then exposed to peroxidase block for 10 minutes. If chondroitinase ABC (ABC) digestion
was indicated, the tissue sections were then treated with 0.1 U/mL ABC (Seikagaku America,
Falmouth, MA) dissolved in 100mM Tris, 10mM EDTA buffer, pH 8.0 for 30 minutes at
37'C. When required, 0.1% pepsin (LabVision, Fremont, CA) was applied for 7 minutes.
Table 4.1: Pre-treatment and antibody dilution factors
Antibody Elastin Fibrillin-1
Information
Clone BA-4 12A5.18
Human Epitope Pepsin ABC
Retrieval
Human Dilution 1:650 1:200
Sniper Dako
Dog Epitope Pepsin ABC
Retrieval
Dog Dilution 1:450 1:150
Sniper Dako
Pig Epitope ABC ABC
Retrieval
Pig Dilution 1:3000 1:200
Sniper Dako
Ferret Epitope ABC ABC
Retrieval
Ferret Dilution 1:500 1:200
Sniper Dako
All slides were Avidin-Biotin blocked following the appropriate epitope retrieval steps. After
incubation with blocking agent Terminator for 10 minutes, tissue sections were lightly drained
and the appropriate antibody, diluted either in Sniper or general antibody diluent (Dako
Cytomation, Carpinteria, CA), was applied. Elastin antibody was applied overnight at 40C,
whereas fibrillin- 1 was applied at room temperature for I hr.
Following primary antibody application, goat anti-mouse IgG secondary antibody and
streptavidin-HRP were applied sequentially for 10 minutes each. Bound antibody was
detected using chromagen DAB.
Epiglottis sections served as positive controls for each antibody. Negative control vocal fold
sections involved application of negative control serum or antibody diluent in place of
primary antibody following appropriate enzymatic pretreatment.
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4.2.4 Histochemical image analysis
4.2.4.1 Image capture
An Axiolab microscope (Zeiss, Thornwood, NY) coupled to an Axiocam CCD camera (Zeiss,
Thornwood, NY) and to an Axiovision image analysis system was used for image recording.
All stained tissue sections were imaged as full-spectrum 1030x1300 8-bit color images.
Background correction was carried out prior to image capture by interactively referencing a
blank field using Axiovision software.
For elastin-stained and alcian blue-stained tissues, further images were taken under controlled
conditions to allow for quantitative analyses of elastin and HA distributions. Specifically,
l0nm bandpass interference filters (Edmund Industrial Optics, Barrington, NJ) centered at
500nm for DAB elastin slides and at 620nm for alcian blue slides were placed between the
microscope light source and slide stage during image capture. 1030x1300 8-bit grayscale
images were recorded.
4.2.4.2 Semi-quantitative image analysis
To facilitate interspecies comparison of staining patterns, average relative staining intensity
has been semi-quantitated on a specimen-by-specimen basis for each antibody/stain using the
methodology described in Chapter 2.
4.2.4.3 Quantitative image analysis
Scarring is often localized to the human superficial LP [12], and therefore a quantitative
comparison of the composition of the superficial LP relative to the overall LP would be useful
in evaluating scar restoration strategies.
Towards this goal, MATLAB was used to separate the LP of each grayscale image into three
subregions meant for human specimens to mimick the traditional LP subdivisions, as
described in Chapter 3. The subregion bordering the epithelium and the subregion bordering
the muscle will be referred to as the superficial third (ST) and the deep third (DT),
respectively. The remaining subregion will be called the intermediate third (IT).
In quantitating HA and elastin distributions, the concepts of optical density (OD) and
integrated optical density (IOD) were used, as described in Chapter 3. For the alcian blue
images, hyaluronidase-treated and non-hyaluronidase treated sections from each specimen
were first registered using MATLAB prior to segmentation into subregions. After image
registration, the OD for each hyaluronidase treated pixel was subtracted from the OD of the
corresponding non-hyaluronidase treated pixel to yield an OD representative of HA presence.
This difference OD was used in HA IOD calculations.
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Once subregions had been defined, IODs for the overall LP and each LP subregion were
calculated for each elastin and HA specimen. The subregional IODs were normalized by
dividing by the overall lamina propria-IOD (LP-IOD) for that specimen, yielding regional
fractional IODs.
4.2.5 Statistical analyses
Mean HA and desmosine levels in the LP of each animal species were compared to those of
human LP using an unpaired student t-test. Differences were considered statistically
significant at a level of p<0.05.
4.3 Results
4.3.1 Biochemical results
Figures 4.1 illustrates the average LP desmosine content per milligram total protein for all
four species. Results are reported as average + standard error of the mean. Animal model LP
desmosine concentrations were not statistically distinguishable from that of human LP. Due
to the dependence of the desmosine content of elastin on species, a statistical similarity
between human and animal model desmosine does not necessarily imply similar levels of
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Figure 4.1: Desmosine content by species. No statistically significant differences were found between the
mean desmosine levels for pig , dog or ferret and that for humans, p>0.05.
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elastin. However, a comparison of desmosine levels among species can give an indication of
order of magnitude differences in elastin content.
Figure 4.2 depicts average HA concentrations in each species' LP and in the hyaline cartilage
controls. The HA levels in the three animal model LPs were significantly different from that
of human LP, (dog: p<3.1x10 5 , pig: p<1.5 x10-5, ferret: p<6.6 x10 4 ), although human LP HA
content was not statistically distinguishable from that of the hyaline cartilage controls.
No statistically significant differences in human LP desmosine or HA concentrations with
gender were noted (data not shown), although this result is likely a reflection of the limited
human specimen set. For hyaline cartilage controls, the average HA concentration was within
the range cited in literature for normal hyaline cartilage [16]. The desmosine content of the
controls was negligible, also in agreement with data for normal hyaline cartilage (data not
shown).
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Figure 4.2: Hyaluronan content by species. Mean HA levels in the animal models were significantly
different from average human hyaluronan, (dog: p<3.1x10-5 , pig: p<1.5 x10-5, ferret: p<6.6 x10-4).
4.3.2 Histochemical results
Figure 4.3 shows representative LP staining for elastin and fibrillin- 1. Figure 4.4 displays
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representative images of non-hyaluronidase treated and hyaluronidase treated LP sections
stained with alcian blue. Alongside these full-spectrum images, the corresponding OD
difference images used for HA spatial quantitation have been displayed in pseudocolor to
enhance visualization. The MATLAB-defined ST and DT subregions used in image
quantitation are outlined in dark blue in each pseudocolored image. Semi-quantitative staining
results for elastin, fibrillin- 1, and HA are displayed with respect to the species-specific
schematics in Figure 4.5.
In describing the histochemical results, the segmentation of the LP of each species into
superficial, intermediate, and deep regions developed in Chapter 2 will be used. From Figure
4.5, it can be seen that human, dog, and ferret HA staining tended to be most intense in the
intermediate LP. The highest staining for HA in pigs was along the superficial LP-epithelial
border and in the inferior regions of the intermediate LP. Elastin appeared to be more
superficially-localized in dogs and ferrets than in humans. For pigs, elastin was more evenly
distributed throughout the LP than in the other species. In humans, relative staining for
fibrillin-1 tended to be low in the IT region stained most deeply for elastin. In addition, the
human fibrillin-1 staining distribution was more superficially localized in comparison to
elastin staining. Dogs also displayed more superficially oriented staining for fibrillin-1
relative to that for elastin. In ferrets, fibrillin-1 staining was high in the deep regions of the
tissue, where elastin staining was relatively low. The pig fibrillin-1 staining more closely
followed elastin staining than it did in the other species analyzed. Interestingly, regions
staining deeply for both HA and elastin in humans, dogs, and ferrets tended have relatively
low staining for fibrillin-1.
Figures 4.6 and 4.7 illustrate the average fractional IODs for elastin and HA, respectively, in
the ST, IT, and DT subregions of each species. The corresponding average fractional areas
associated with each subregion for each species are indicated in the figure legends. For pigs,
elastin was relatively evenly distributed throughout the tissue, whereas the quantitative trends
in elastin distribution for dogs and ferrets were essentially mirror-images of that seen in
humans. The HA fractional IODs for dogs and ferrets clearly reflected the marked increase in
HA staining observed in transitioning from the superficial LP to the intermediate LP in these
animals. Although the staining for HA in the majority of the pig IT was relatively low (see
Figure 4.4), the fraction HA measured for pig IT reflects the relatively intense staining for HA
in the inferior IT region.
These quantitative IOD results can be used to calculate the concentrations of elastin and HA
in various regions of the LP. For example, for dogs, the fraction of HA present in the IT
according to IOD calculations is approximately 0.47±0.02, and mean HA concentration in the
overall dog LP is approximately 0.029+0.003 mg HA per mg total protein. The fractional area
represented by the IT is about 0.31+0.01. Thus, assuming fractional protein in a region to be
proportional to the fractional area of that region, the average concentration of HA in the dog
IT is approximately 0.044+0.005 mg per mg IT total protein.
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Figure 4.3: Representative staining for elastin and fibrillin-1 by species. (A, C, E, G): elastin staining in
human, dog, pig, and ferret, respectively; (B, D, F, H): fibrillin-1 staining in human, dog, pig, and ferret,
respectively. Scale bars =500 Im.
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Figure 4.4: Representative alcian blue staining for hyaluronan detection. (A, D, G, J): alcian blue staining
of non-hyaluronidase treated human, dog, pig, and ferret LP, respectively; (B, E, H, K): hyaluronidase
treated human, dog, pig, and ferret tissues. (C, F, I, L): corresponding pseudocolored OD difference
images used in quantitative histology. The regions outlined in dark blue in (C, F, I, L) indicate the ST and
DT regions. Scale bars =500 pm.
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Figure 4.5: Semi-quantitative images for elastin, fibrillin-1, and hyaluronan staining. (A, D, G, J):
average relative elastin staining in human, dog, and pig, and ferret, respectively; (B, E, H, K): average
relative fibrillin-1 staining in human, dog, pig, and ferret, respectively; (C, F, I, L): average relative
hyaluronan staining in human, dog, pig, and ferret, respectively.
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Figure 4.6: Fraction of overall elastin IOD by region. The average fractional areas calculated for each
species by region: Human: (ST: 0.312±0.005, IT: 0.358+0.005, DT: 0.330±0.009); dog: (ST: 0.358±0.017,
IT: 0.318+0.006, DLP: 0.324±0.019); pig: (ST: 0.304±0.003, IT: 0.375+0.001, 0.321±0.004); ferret: (ST:
0.357±0.012, IT: 0.343+0.003, 0.300±0.015).
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Figure 4.7: Fraction of overall hyaluronan IOD by region. The average fractional areas calculated for
each species by region: Human: ST: (0.310±0.010, IT: 0.350+0.008, DT: 0.340±0.014); dog: (ST:
0.351±0.015, IT: 0.312+0.007, DT: 0.337±0.018); pig: (ST: 0.291+0.006, IT: 0.381+0.001, DT: 0.328±0.006);
ferret: (ST: 0.327±0.009, IT: 0.363+0.004, DT: 0.310±0.013).
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4.4 Discussion
4.4.1 Biochemical results
Desmosine is an amino acid found only in cross-linked elastin [14]. For human aorta, a
multiplicative conversion factor of roughly 0.030 has been measured to relate picomoles
desmosine to micrograms elastin [14]. For pig and dog aorta, conversion factors of 0.037 and
0.044, respectively, have been measured [14]. Application of these conversion factors to
mean LP desmosine values indicate that elastin constitutes approximately 8.5+2.1%,
6.0+0.7%, and 7.5+1.2% of human, dog, and pig LP total protein, respectively. These
estimated LP elastin concentrations are on the same order as that of tendon [17].
For humans, the interspecimen variations in desmosine content were greater than those
observed for the animal models. Previous histological analyses indicate that the elastin
content of the adult human LP increases with age [4]. Thus, the larger interspecimen
variability in human LP desmosine levels may be attributable, in part, to the broader age range
represented by the human specimens than by the animal specimens. The variability in human
desmosine levels may, on the other hand, be a reflection of the natural variability in human
LP elastin concentration. The human sample number in this study was not sufficient for these
distinctions to be made.
Although the human LP HA content was statistically similar to that of hyaline cartilage
controls (p>0.05), the mean HA levels in the animal model LPs were approximately 3-4 times
greater than that in human LP. The increased post-mortem age of the human specimens may
in part account for the observed differences between human and animal model LP HA
content, although further studies would be required to clarify the origin of this interspecies
variation in LP HA levels. Given these caveats, the HA concentrations presented in this study
can be considered to provide order of magnitude assessments of LP HA levels, placing this
tissue within the context of other biochemically and biomechanically well-characterized
tissues.
4.4.2 Histochemical results
On a qualitative level, the LP elastin distributions observed in human, dog, and pig LPs in the
present study closely matched the elastin distributions noted in the literature for these species
[1, 2, 4, 6, 10, 11]. From Figure 4.6, dog and ferret appear to follow an elastin concentration
profile that is essentially the mirror-image of that of humans, with staining for elastin being
lowest in the deep third and relatively high in the superficial and intermediate thirds. This
observation could have implications for the suitability of these two animals for evaluating
implants meant to restore function to scarred human superficial LP.
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Fibrillin- 1 is one of the microfibrils associated with elaunin and mature elastic fibers. It is
also a constituent of oxytalin, an elastic molecule that contains no elastin component [18].
Oxytalin has been observed to be often associated with tissue regions that bear high tensile
stress [18]. If it is assumed that the ratio of fibrillin- I to other elastin-associated microfibrils
remains approximately constant throughout the LP, then the spatial distribution of fibrillin-1,
when interpreted in conjunction with elastin staining, gives an indication of the spatial
arrangement of oxytalin versus that of elastin-containing elastic fibers.
In humans and dogs, the more superficial localization of fibrillin- 1 staining relative to that of
elastin seems to indicate that these superficial regions may experience higher tensile stress
than underlying LP regions. In ferret LP, fibrillin- 1 staining was shifted towards the deep LP
relative to elastin staining, implying that ferrets may experience relatively high tensile stress
in the deep LP. Interestingly, fibrillin- 1 staining tended to the relatively low in humans, dogs,
and ferrets in regions of combined high elastin and high hyaluronan staining. The reason for
this is unclear, although a distinct microfibril may be responsible for organizing elastin in
these regions.
For ferrets, humans, and dogs, HA appeared to be most concentrated in the IT. HA staining in
pigs was high along the superficial LP-epithelial border and in the inferior region of the IT,
although in the remainder of the IT, HA staining was relatively low. HA is involved in
lubrication and in the dissipation of impact and compressive stresses [19]. Thus, these
interspecies differences in HA localization may imply corresponding differences in the
regional stresses sustained by their LPs.
Comparing HA semi-quantitative staining patterns to those for chondroitin 6-sulfate (C6S)
developed in Chapter 2, it appears that C6S staining in both ferrets and dogs is primarily
localized to the oblong IT subregion which stains relatively intensely for both elastin and HA.
The reasons for the localization of ferret and dog C6S staining to IT subregions are unclear,
although it may indicate that the C6S proteoglycan (PG) in this region is a large aggregating
PG. Based on the background staining for aggrecan and the disparity between versican and
C6S staining distributions in dog and ferret LPs observed in Chapter 2, there seem to be two
primary possibilities: either the sulfation of versican-associated chondroitin sulfate side chains
varies with LP region, or a distinct PG is responsible for this C6S staining. A similar co-
localization of C6S with high HA and elastin staining regions was not noted in humans or
pigs.
The present study is, to the author's knowledge, the first to quantify the HA and elastin
concentrations in the human vocal fold LP and in three animal model LPs. Quantitative
histochemistry has been used to provide a key link between histological and biochemical data,
allowing the HA or desmosine content of specific LP subregions to be calculated. The
distribution of tensile stresses in the LP, as indicted by fibrillin-1 staining, has similarly been
investigated for all four species. These histological and quantitative biochemical results
should yield deeper insight into the structure and function of the LP and methods to repair it.
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Chapter 5. Cellularity and Extracellular Matrix Turnover
5.1 Introduction
Tissue cellularity is altered during a number of physiological and pathological processes,
including growth, aging, degeneration, and repair. Thus, it is important that the normal
cellularity of the vocal fold lamina propria (LP) be known in seeking to treat LP scarring.
Although several histological studies of vocal fold LP cell types have been published [1-5],
the cellular density in the LPs of human and animal models has not been quantitatively
assessed.
Also altered in disease states, aging, and repair is the rate extracellular matrix (ECM) turnover
in a tissue. Changes in ECM turnover with senescence in rat vocal fold LP have been
investigated using RT-PCR [6, 7]. These results have yielded insight into the normal ECM
turnover; however, spatial variations in the expression of various enzymes or newly
synthesized molecules within normal LP are not captured by these studies. Since scarring
tends to be limited to the human superficial LP [8], it is important to understand normal
turnover in this LP subregion.
The present study has analyzed the DNA content of human, pig, dog, and ferret vocal fold LP
as a measure of tissue cellularity. Spatial variations in vocal fold LP ECM turnover, as
indicated by immunostaining for tropoelastin, procollagen type I, and matrix metalloprotease I
(MMP-1), have also been investigated.
5.2 Materials and methods
5.2.1 Tissue samples and preparation
The tissue specimens and controls used in this study and their preparation for biochemical or
histological assays were the same as in Chapter 2.
5.2.2 Biochemical analyses
5.2.2.1 Tissue digestion and total protein quantitation
Specimens allocated for biochemical analyses were digested with proteinase K (Worthington
Biochemical, Lakewood, NJ) for 24 hrs at 60'C as described in Chapter 2. Total protein in
the sample digests was quantitated in triplicate via amino acid analysis by AAA Service
Laboratory, Inc. (Boring, OR) as described in Chapter 2.
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5.2.2.1 DNA quantitation
The Picogreen assay (Molecular Probes) was used to measure the DNA content of human,
dog, and pig digests in triplicate and of ferret digests in duplicate. Calf thymus DNA (Sigma-
Aldrich) was used as the standard for this assay. Based on combined information from the
online Database of Genome Sizes and Gregory [9], the following conversion factors were
used to calculate cellular content from measured DNA values: 1.) pigs: 6.6pg DNA/cell, 2.)
dogs: 6.3pg DNA/cell, and 3.) humans: 6.9pg DNA/cell. The conversion factor used for
ferrets, 6.2pg/cell, was based on average DNA concentrations for measured species within the
Order Carnivora [9], of which ferrets are a member.
5.2.3 Immunohistochemical analyses
The antibodies, epitope retrieval methods, and dilutions used are noted in Table 5.1. Unless
otherwise stated, immunohistochemical steps took place in a humidified environment at room
temperature, and immunohistochemical reagents were purchased from Biocare Medical
(Walnut Creek, CA).
For sections receiving heat-induced epitope retrieval, deparaffinization, peroxidase blocking,
and epitope retrieval were carried out simultaneously by exposing slides to Reveal for 20
minutes at 95'C in a temperature controlled pressure-cooker (Biocare Medical Walnut Creek,
CA).
For slides exposed to enzyme-based epitope retrieval, tissue sections were deparaffinized in
xylene, taken to water using graded ethanol baths, and then exposed to peroxidase block for
10 minutes. When required, 0.19% trypsin was applied for 7 minutes.
Table 5.1: Pre-treatment and antibody dilution factors
Antibody Clone/Antigen Epitope Human Dog Pig Ferret
Retrieval Dilution Dilution Dilution Dilution
Procollagen type I M-58 Trypsin 1:650 1:450 1:3000 1:500
Sniper Sniper Sniper Sniper
MMP-1 Recombinant Reveal 1:200 1:150 1:200 1:200
human MMP- 1 Dako Dako Dako Dako
Tropoelastin Ala-Lys-(Ala)3-Lys- N/A 1:1600 1:800 1:1600 1:800
(Ala)3-Lys-Tyr Dako Dako Dako Dako
All slides were Avidin-Biotin blocked following the appropriate epitope retrieval steps. After
incubation with blocking agent Terminator for 10 minutes, tissue sections were lightly drained
and the appropriate antibody, diluted either in Sniper or general antibody diluent (Dako
Cytomation, Carpinteria, CA), was applied. Procollagen type I antibody was applied
overnight at 4'C, whereas remaining antibodies were applied for 1 hr at room temperature.
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Following primary antibody application, appropriate secondary antibody and streptavidin-
HRP were applied sequentially for 10 minutes each. Bound antibody was detected using
chromagen DAB.
Epiglottis sections served as positive controls for each antibody. Negative control vocal fold
sections involved application of negative control serum or antibody diluent in place of
primary antibody following appropriate enzymatic pretreatment.
5.2.4 Immunohistochemical image analysis
5.2.4.1 Image capture
An Axiolab microscope (Zeiss, Thornwood, NY) coupled to an Axiocam CCD camera (Zeiss,
Thornwood, NY) and to an Axiovision image analysis system was used for image recording.
All stained tissue sections were imaged as full-spectrum 1030x1300 8-bit color images.
Background correction was performed prior to image capture by interactively referencing a
blank field using the Axiovision software.
5.2.4.2 Semi-quantitative image analysis
To facilitate interspecies comparison of staining patterns, average relative staining intensity
was semi-quantitated for procollagen type I, MMP-1, and tropoelastin on a specimen-by-
specimen basis using the methodology described in Chapter 2.
5.2.5 Statistical analysis
The LP cellularity of each animal species was compared to that of humans using an unpaired
student t-test. Differences were considered statistically significant at a level of p<0.05.
5.3 Results
5.3.1 Biochemical results
Figure 5.1 presents cell number per milligram total protein in pig, human, ferret, and dog
vocal fold LPs. Results are reported as average ± standard error of the mean. To place the
cell densities in context, the measured cellularity of pig hyaline cartilage controls have been
included in Figure 5.1. Cellularity in dogs was statistically indistinguishable from that in
humans (p>0.05), although pig and ferret cell densities were significantly different from
human cellularity (pig: p<0.0 18, ferret: p<0.033).
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Figure 5.1: LP cellularity by species as compared to hyaline cartilage. Pig and ferret cellularity were
significantly different from human cellularity (pig: p<0.018, ferret: p<0.033). In addition, the cellularity
of hyaline cartilage was statistically different from human vocal fold LP (p<0.011).
5.3.2 Histochemical results
Figure 5.2 depicts representative tropoelastin and MMP- 1 staining for all species, whereas
Figure 5.3 illustrates representative procollagen type I staining. Semi-quantitative staining
results for tropoelastin, MMP- 1, and procollagen type I are displayed with respect to the
species-specific schematics in Figure 5.4.
In describing the histochemical results, the segmentation of the LP of each species into
superficial, intermediate, and deep regions developed in Chapter 2 will be used. As shown in
Figure 5.2, pig tropoelastin staining was relatively evenly distributed throughout the LP,
although there was a moderate increase in staining observed in the deep LP. In humans, the
tropoelastin distribution was more superficially localized than the elastin distribution
described in Chapter 4, although tropoelastin staining was still more intense in the deep LP
than the superficial LP. Staining for tropoelastin in dogs and ferrets was most concentrated in
the thick superficial rim of tissue along the inferior epithelial-LP border. In the oblong
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Figure 5.2: Representative MMP-1 and tropoelastin staining by species. (A, C, E, G): MMP-1 staining in
human, dog, pig, and ferret, respectively; (B, D, F, H): tropoelastin staining in human, dog, pig, and
ferret, respectively. Scale bars =500 gm.
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Figure 5.3: Representative procollagen type I staining by species. (A, B, C, D): procollagen
type I staining in human, dog, pig, and ferret, respectively. Scale bars =500 pm.
subregion of the dog intermediate LP that stained intensely for hyaluronan and elastin
(Chapter 4), tropoelastin staining could not be distinguished from background. In ferrets,
however, tropoelastin staining was relatively high in the intermediate LP region of intense
elastin and hyaluronan staining (Chapter 4). MMP-1 staining appeared to be high in each
species in the regions documented in Chapter 4 to stain intensely for hyaluronan.
Comparing the procollagen type I staining with the bright field picrosirius staining
distribution noted in Chapter 3, human LP procollagen type I staining seemed to be more
superficially localized relative to total collagen. In pigs, procollagen type I staining tended to
be most intense in the superior portion of the LP. In the more inferior pig LP regions,
however, staining for procollagen type I tended to be low relative to the picrosirius staining
intensity observed in these areas in Chapter 3. Dog and ferret procollagen type I staining
appeared to be relatively low in the oblong subregion of the intermediate LP, which stained
relatively intensely for hyaluronan in both species (Chapter 4).
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Figure 5.4: Semi-quantitative images for tropoelastin, MMP-1, and procollagen type I staining. (A, D, G,
J): average relative tropoelastin staining in human, dog, and pig, and ferret, respectively; (B, E, H, K):
average relative MMP-1 staining in human, dog, pig, and ferret, respectively; (C, F, I, L): average relative
procollagen type I staining in human, dog, pig, and ferret, respectively.
5.4 Discussion
5.4.1 Biochemical results
It is known that a variety of cell types, including fibroblast-like cells, leukocytes, endothelial
cells, and myofibroblasts, are present in the human LP [1]. Approximately 80% of these LP
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cells appear to be fibroblast-like cells [1], and these fibroblast-like cells seem to be the
primary ECM-producing cells of the LP [3].
In general, when the cellularity of a tissue is discussed, the cited cell density usually refers to
the primary ECM-producing cells for that tissue. With respect to this definition, the cell
densities measured in this study should be viewed as first-order estimates of the concentration
of fibroblast-like ECM producing cells in the LP. The cell densities in this study are not exact
measures of LP fibroblast-like cellularity since all cell types present in the dissected vocal
fold specimens contributed to the measured DNA levels. In addition to the non-fibroblast-like
cells in the LP, the LP specimens analyzed still had the overlying epithelium, which is
approximately 3-5 cell layers thick, attached. When the cell number within the epithelium
was estimated based on the surface dimensions of the LP specimens and epithelial cell
diameter, epithelial cells were calculated to constitute 10-30% of measured cell number,
depending on the assumed diameter and number of layers of the epithelial cells (data not
shown). Combining the estimated percentage epithelial cells with the percentage of non-
fibroblast LP cells reported by Catten et al. [1], it is evident that the present DNA measures
provide important, albeit order of magnitude, assessments of LP cellularity.
5.4.2 Histochemical results
With respect to LP ECM turnover, the superficial shift in the tropoelastin staining distribution
observed in humans and pigs relative to the corresponding elastin staining distribution
(Chapter 4) seems to indicate that the elastin turnover in these species is highest in the more
superficial LP regions. Increase in elastic fiber diameter has been linked to decreased elastin
turnover. Hence, the present observations may correlate with previous electron microscopy
studies of the human vocal fold LP, which have noted an increase in elastin fiber diameter
proceeding from the superficial to the deep LP [10].
Procollagen type I staining gives insight into spatial variation in the rate of collagen type I
production and turnover. For humans and pigs, procollagen type I staining tended to be more
superficially oriented than the corresponding staining for total collagen (Chapter 3), indicating
that collagen turnover in the more superficial layers may be higher than in the deeper LP
layers. A higher rate of collagen turnover in the superficial LP of humans would be consistent
with observations of smaller fiber diameters found in the superficial LP versus the deep LP
[11], and these spatial differences in LP turnover may be required for proper human LP
biomechanical function. In humans, the combined intermediate and deep LP is frequently
referred to as the vocal "ligament", since these layers are assumed to balance the tension
between the underlying muscle and the superficial LP [12]. The more highly cross-linked
collagen fibers characteristic of the deep LP, which may result in part from lower collagen
turnover in the deep LP relative to the superficial LP, may functionally allow this tension to
be more effectively transmitted than if the fibers were less highly cross-linked. In the animal
models, possible physiological grounds for observed regional differences in procollagen type
I production relative to collagen presence are unclear.
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MMP- I is associated with the turnover of a variety of ECM molecules, including collagens
type I and III and versican [13]. Comparing semi-quantitative MMP- 1 staining distributions
with those developed for total collagen (Chapter 3) and versican (Chapter 2), it appears that
the MMP-1 staining pattern in all four species is only loosely correlated with those of total
collagen and versican. Moreover, the staining patterns for procollagen type I do not seem to
follow those for MMP-1 in any of the species analyzed. In dogs, ferrets, and humans, in
particular, the staining of MMP- 1 was often highest where staining for procollagen type I was
correspondingly low. MMP-1 staining did, however, appear to correlate closely with
hyaluronan staining in all species studied. This is an interesting observation, since MMP-1
production seems to be inhibited by hyaluronan for certain cell types [14]. Since the MMP-1
antibody used in this study recognizes both latent and active forms of MMP-1, the MMP-1
detected in the hyaluronan rich LP regions may be primarily in latent form.
This chapter has presented first order measures of vocal fold LP cellularity. Additionally, the
spatial distribution of several important indicators of ECM turnover have been
immunohistochemically analyzed, revealing significant regional variations in MMP-1 levels
and in the production of tropoelastin and procollagen type I in the LP. These spatial
variations in ECM turnover may be important in maintaining an LP with proper
biomechanical function.
5.5 Literature cited
1. Catten, M., et al., Analysis of cellular location and concentration in vocal fold lamina
propria. Otolaryngology-Head and Neck Surgery, 1998. 118(5): p. 663-667.
2. Hirano, M., K. Sato, and T. Nakashima, Fibroblasts in geriatric vocal fold mucose.
Acta Oto-Laryngologica, 2000. 120(2): p. 336-340.
3. Hirano, M., K. Sato, and T. Nakashima, Fibroblasts in human vocal fold mucosa. Acta
Oto-Laryngologica, 1999. 119(2): p. 271-276.
4. Pawlak, A.S., et al., Immunocytochemical study of proteoglycans in vocal folds.
Annals of Otology Rhinology and Laryngology, 1996. 105(1): p. 6-11.
5. Garrett, C.G., J.R. Coleman, and L. Reinisch, Comparative histology and vibration of
the vocal folds: Implications for experimental studies in microlaryngeal surgery.
Laryngoscope, 2000. 110(5): p. 814-824.
6. Ding, H. and S.D. Gray, Senescent expression of genes coding tropoelastin, elastase,
lysyl oxidase, and tissue inhibitors of metalloproteinases in rat vocal folds:
Comparison with skin and lungs. Journal of Speech Language and Hearing Research,
2001. 44(2): p. 317-326.
7. Ding, H. and S.D. Gray, Senescent expression of genes coding collagens, collagen-
degrading metalloproteinases, and tissue inhibitors of metalloproteinases in rat vocal
folds: Comparison with skin and lungs. Journals of Gerontology Series a-Biological
Sciences and Medical Sciences, 2001. 56(4): p. B145-B152.
8. Rosen, C.A., Vocal fold scar - Evaluation and treatment. Otolaryngologic Clinics of
North America, 2000. 33(5): p. 108 1-+.
80
9. Gregory, T.R., Nucleotypic effects without nuclei: Genome size and erythrocyte size
in mammals. Genome, 2000. 43(5): p. 895-901.
10. Sato, K. and M. Hirano, Age-related changes of elastic fibers in the superficial layer of
the lamina propria of vocal folds. Annals of Otology Rhinology and Laryngology,
1997. 106(1): p. 44-48.
1. Ishii, K., et al., Ultrastructure of the lamina propria of the human vocal fold. Acta Oto-
Laryngologica, 1996. 116(5): p. 778-782.
12. Kurita, S., et al., The Layer Structure of the Vocal Fold - Age-Dependent Variations.
Folia Phoniatrica, 1980. 32(3): p. 210-210.
13. Somerville, R.P.T., S.A. Oblander, and S.S. Apte, Matrix metalloproteinases: old dogs
with new tricks. Genome Biology, 2003. 4(6).
14. Shimizu, M., et al., Hyaluronan inhibits matrix metalloproteinase-1 production by
rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. Journal of
Rheumatology, 2003. 30(6): p. 1164-1172.
81
Chapter 6. Final Observations, Summary, and Recommendations
6.1 Final observations and summary
To rationally design an implant material for scar restoration, it is important to have a more
complete understanding of vocal fold lamina propria (LP) biochemistry and microstructure
than is currently in literature. This dissertation presents the following critical insights into
normal human LP biochemical structure:
1.) quantitative analysis of collagen, elastin, hyaluronan (HA), and
proteoglycan (PG)/associated sulfated glycosaminoglycan (sGAG) presence;
2.) quantitative examination of the spatial distributions of collagen, elastin, and HA, and
qualitative investigation of the spatial distributions of specific PG/sGAG types; and
3.) assessment of cellularity and spatial variations in extracellular matrix (ECM) turnover.
Similar analyses have been carried out on the vocal fold LPs of normal dog, pig, and ferret
towards identifying an appropriate animal model for implant trials. Highlights from these
biochemical and histological analyses are described below.
6.1.1 Biochemical results
Total collagen, elastin, HA, and sGAG by LP dry weight are shown in Figure 6.1. Focusing
collagen and elastin, the human vocal fold LP contains approximately 20% less collagen than
the dermis (Table 6.1); however, mean human LP elastin levels are approximately 5 times (by
dry weight) the upper range of dermis elastin levels. Thus, the vocal folds may, to a first
order, be expected to show a lower tensile strength and a higher elastic response than dermis.
These comparisons, although neglecting important microstructural differences between these
tissues, serve to place the LP in the context of biochemically and biomechanically well-
characterized tissues.
Based on overall LP biochemical similarity alone (i.e., not accounting for differences in LP
morphology or in biomolecule distribution and ultrastructure), it would appear that dogs are
most similar to humans of the animal models studied. In the author's opinion, however, the
more significant interspecies LP differences, in terms of assessing animal model suitability,
were observed at the microstructural and morphological levels.
Table 6.1: Collagen and elastin in various tissues by dry weight [1]
Percent of Dry Weight
Tissue Elastin Collagen
Dermis 0.6-2.1 71
Lung 3-7 10
Ligamentum nuchae 75 17
Achilles tendon 4-5 86
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Figure 6.1: Combined LP biochemical results by dry weight. Total protein was assumed to constitute
80% of dry weight on average, matching unpublished observations. Error bars have been excluded for
the purpose of clarity. Asterices indicate molecules in a given species found to be present in significantly
different levels relative to those in humans. Elastin levels have been estimated from aortic desmosine
levels listed in Chapter 3, with the dog conversion factor being used for ferrets.
6.1.2 Microstructural results
From quantitative histological studies described in chapters 3 and 4, the distribution of
collagen and elastin within dog and ferret LP was seen to be inversely related to human
collagen and elastin distributions. Elastin and collagen in the pig superficial LP also seemed
to be more prevalent than in human superficial LP, although the spatial distributions of
collagen and elastin in pig more closely matched those of human than did the other two
animal models (See Chapters 3,4). Collagen and elastin are critical regulators of tissue
biomechanical function. Therefore, marked human versus animal model variations in the LP
distributions of these molecules may have implications for the appropriateness of specific
animal models for use in human superficial LP restoration studies.
Immunohistochemical analyses described in Chapter 4 indicate that collagen types I and III
are the primary collagen types in the midmembranous LP. The dominance of collagen types I
and III seems to emphasize the repetitive compressive and tensile forces experienced in the
midmembranous LP and the requirements for tissue resilience. The cyclic compressive and
impact forces sustained by the LP appear to be further reflected in the diffuse versican
staining noted in dog, human, and pig LPs (Chapter 2), and the fibrillin-1 staining observed in
83
Chapter 3 seems to indicate that tensile stresses, in humans, may be particularly high in the
superficial LP. Staining for collagen type IV (Chapter 4) and heparan sulfate PG (Chapter 2)
in the LP ECM apart from basement membranes seems to imply significant shear forces may
be experienced deep within human and pig LP.
Although total sGAG levels in the LPs of the three animal models could not be statistically
distinguished from that of humans (p>0.05, Chapter 2), the staining patterns for specific
PG/sGAG classes varied significantly with species. In addition, intraspecies comparisons of
specific PG/sGAG staining patterns revealed a number of microstructural subdivisions within
the dog and ferret LPs that have not, to the author's knowledge, been previously described.
These regions were indicated by boundaries or by dashed marks (intended to indicate
observed fiber orientation) within the LP schematics developed in Chapter 2. The marked
differences in the microstructural organization of human, dog, and ferret LPs documented in
these schematics may have bearing on the appropriateness of dogs and ferrets as potential
animal models in human LP restoration studies.
6.1.3 Morphological results
In developing the LP schematics introduced in Chapter 2, macroscopic differences in LP
geometry among species were also noted. Although some alterations in the overall size and
shape of each species' LP from its in vivo state due to the excision of the midmembranous LP
from its attachments post-fixation should be expected, certain statements concerning
macroscopic differences in LP morphology among species can still be made with confidence.
Interspecies LP geometrical variations are particularly evident when one examines the shape
of the LP-muscle boundary characteristic for a given species. The muscle-LP boundary in
dogs and ferrets tends to be concave relative to the epithelial-LP boundary, whereas the
muscle-LP boundary of human and pig LP is convex relative to the epithelial-LP boundary.
Thus, if the center of mass of the human LP were calculated, it would lie outside of the LP, in
the underlying muscle layer. The same would be true of pigs. The center of mass of dog and
ferret LP, however, would be within the LP itself. These basic geometrical/LP mass
distribution differences indicate that the observed similarity between human and dog vocal
fold vibration [2] may result from different structural origins. This vibratory similarity has
been one of the primarily grounds for the historical use of dogs as an animal model in LP
research.
6.2 Recommendations
Based on examination of combined biochemical, structural, and morphological information, it
is the author's assessment that pigs are the best model of the three potential animal models
analyzed for implant studies seeking to restore function to the human superficial LP.
Although pigs differ from humans in the distribution of hyaluronan (see Chapter 4) and pig
LP molecular organization seems to be more homogenous than that of the human LP, overall,
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the composition and microstructure of the pig superficial LP region appears to be more
similar to that of humans than do dog and ferret superficial regions.
6.3 Literature cited
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Chapter 7. Contributions and Future Directions
7.1 Contributions
To the authors' knowledge, this dissertation presents the first quantitative measures of: (1)
total collagen, (2) elastin, (3) hyaluronan (HA), and (4) proteoglycans (PG)/associated
sulfated glycosaminoglycans (sGAG) in normal human vocal fold lamina propria (LP). These
quantitative measures place this tissue in the context of other well-characterized tissues,
establishing bounds on the expected contribution of various extracellular matrix (ECM)
components to tissue biomechanical behavior. Immunostaining for specific collagen types
and PG/sGAG classes has been carried out, yielding insight into the primary stresses
sustained by the LP (see Chapters 2 and 3). Moreover, PG/sGAG types previously believed
to be intracellularly or basement membrane localized, such as versican, chondroitin 6-sulfate,
and heparan sulfate proteoglycan [1], have been identified in the LP ECM. Since vocal fold
scarring is generally localized to superficial LP, quantitative histology has been used to
calculate the percent of total collagen, elastin, and HA within specific LP regions (Chapters 3
and 4). Spatial variations in LP ECM turnover, as indicated by immunostaining for
tropoelastin, procollagen type I, and matrix metalloprotease I (MMP-1), have also been
investigated (Chapter 5), variations which may be important in maintaining proper LP
physiology. In addition, total LP cellularity has been quantified (Chapter 5). The results from
these analyses significantly advance the understanding of normal human LP biochemistry and
microstructure and establish benchmarks for the evaluation of LP scar restoration strategies.
Similar biochemical and histological studies have been carried out on the LPs of three
potential animal models: dog, pig, and ferret. Observation of LP biomolecule staining
patterns have resulted in identification of microstructurally-related subdivisions in each
animal model LP. Recognition of these LP subdivisions may yield insight into the adaptation
of LP microstructure to the phonatory needs of each animal, just as the subdivision of human
LP into layers heightened understanding of its structure-function relationship.
Comparison of animal and human LP biochemical and histological results seems to imply that
dogs, the most common animal model in vocal fold research, may not be the most appropriate
for human superficial LP restoration studies. Of the three animal models examined, pigs
appear to be the most similar to humans in terms of LP composition, microstructure, and
morphology (see Chapter 6).
Moving towards in vitro studies of implant materials, initial methods for vocal fold LP cell
isolation and growth have been established (see Appendix B).
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7.2 Future directions
Vocal fold research is a relatively nascent field with numerous exciting areas for future
research. Potential avenues for future study include:
1.) With the goal of implant design and evaluation:
a) the use of the developed biochemical and histological benchmarks for implant
material evaluation in vitro
b) analysis of biochemical and histological alterations characteristic of scarred LP
c) development of appropriate biomechanical measuring equipment and
establishment of relevant LP biomechanical benchmarks. Correlation of
biomechanical data with the present biochemical and microstructural results may
yield deeper insight into the LP structure-function relationship.
2.) On a more basic science level:
a) investigation of the effects of biomechanical forces on vocal fold fibroblast
cellular behavior
b) quantitation of individual PG/sGAG and collagen types
c) analyses aimed at understanding the physiology of vocal fold LP fibroblasts
relative to that of fibroblast-like cell from other tissues.
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Appendix A. Optical Coherence Tomography Imaging of the
Larynx
A.1 Background
In determining whether to pursue development of biochemical versus biomechanical
benchmarks for implant design and evaluation, initial feasibility studies were carried out for
both approaches. Optical coherence tomography (OCT)-based elastography is one method
that was investigated for biomechanical assessment of vocal fold lamina propria (LP). OCT
elastography has several advantages over traditional bulk rheological methods, such as cone-
and-plate rheometers. Importantly, OCT elastography can potentially give information
concerning spatial variations in LP biomechanical properties without requiring removal of the
LP from its larynx attachments and from the effects of vocalis muscle tension.
For OCT elastography to be feasible, it is important that landmark LP features at various
depths be resolvable and trackable with deformation. However, conventional OCT images of
human vocal fold LP were relatively homogeneous in appearance near the vocal fold free
edge, making such trackable features difficult to identify (see Figure A.2, which shows an
OCT image of the human LP near the free edge. In contrast, Figure A. 1 depicts the inferior
surface of pig vocal fold LP, which is less homogenous than the free edge due to the presence
of glandular structures, but which is not of high interest for biomechanical assessment).
Although polarization-sensitive (PS)-OCT, which is sensitive to collagen fiber organization,
yielded more differentiated LP images, significant variability in resulting banding patterns
was noted across human specimens (the origin of these banding patterns is described below,
data not shown). Thus, the relationship of these images to the human LP microstructure was
unclear, and larger-scale examination and correlation of ex vivo OCT/PS-OCT vocal fold
images with parallel histology would have been required before elastography stress-strain
analyses could begin. The actual elastography deformation experiments and their correlation
with applied stresses would in themselves require extensive methodology development and
verification before biomechanical data could be gathered using this imaging tool. Therefore,
the pursuit of OCT-based elastography for biomechanical assessment of the vocal fold LP was
determined not to be feasible at that point. The results of these initial OCT imaging studies of
the vocal fold are, however, useful to the laryngological community in evaluating the
applicability of this imaging technology to the in situ diagnosis and monitoring of laryngeal
pathologies and implants, and therefore, important outcomes will be discussed below.
A.2 Optical coherence tomography : introduction
OCT is a relatively new optical imaging modality that allows high resolution, cross-sectional
imaging of tissue microstructure. Although OCT was first applied in 1991 to imaging
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optically transparent structures, such as the anterior eye and retina [1, 2], subsequent
technological advances have enabled high resolution imaging of nontransparent tissue in the
cardiovascular system [3] and the gastrointestinal [4], urinary [5], and female reproductive
tracts [6]. In addition, the application of OCT to surgical guidance [7] and carcinoma
detection [6, 8] has been explored.
The aforementioned imaging studies have demonstrated that OCT is particularly informative
in tissues in which non-keratinized epithelium is separated from underlying stroma by a
smooth basement membrane zone, suggesting that OCT may have a strong clinical relevance
in laryngology. This indication is further strengthened by several features of the OCT system
itself: 1) OCT imaging can be performed in situ and nondestructively, enabling the imaging of
tissue for which biopsy should be avoided or is impossible; 2) OCT can image with an axial
resolution of 1-15 tm and to a depth of 1 to 3 mm in non-transparent tissue; 3) imaging can
be performed in real-time, without the need to process a specimen, as in conventional biopsy,
and without the need for a transducing medium, as in ultrasound imaging; 4) and OCT is
fiber-optically based and can thus be interfaced to a wide range of instruments including
catheters, endoscopes, laparoscopes, and surgical probes. Before presenting and discussing
OCT images of specific laryngeal structures, it is useful to briefly describe the basis by which
OCT systems form subepithelial images.
OCT systems perform high-resolution tomographic imaging by measuring light backscattered
or backreflected from internal tissue structures. OCT imaging is analogous to ultrasound B
mode imaging, but is based on the detection of infrared light waves, instead of sound. Like
acoustic waves, light is characterized by its propagation direction. Light is distinct, however,
in that it has an additional vector characteristic known as polarization. The polarization
direction is orthogonal to the propagation direction and can be influenced by the medium in
which the light propagates. This is known as birefringence. Polarization measurements can be
used to provide additional insights into the microscopic structure and integrity of tissues. PS-
OCT exploits birefringence as an additional contrast mechanism for imaging tissue, and PS-
OCT will be discussed in further detail in a later section.
The analogy with ultrasound is a useful starting point for understanding the basics of OCT. In
ultrasound, a high frequency acoustic pulse travels into the tissue and is reflected or
backscattered from internal structures having different acoustic properties. The magnitude
and the delay time of the echoes are electronically detected, and the structural properties of
the internal tissues are determined from the measured signals. In OCT, imaging is performed
by measuring the echo delay time and magnitude of light backreflected or backscattered from
internal structures with distinct optical properties. Unlike in ultrasound, though, the speed of
light is very high, rendering electronic measurement of the echo delay time of the reflected
light impossible. OCT systems circumvent this limitation by using low coherence
interferometry to characterize optical echoes.
Two or three dimensional images are produced by scanning the light beam across the sample
and recording the optical backscattering versus depth at different transverse positions. The
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resulting data is a two or three dimensional representation of the optical backscattering of the
sample on a micron scale.
A.3 OCT imaging of the larynx: preliminary results
To assess the potential value of OCT imaging technology to improving visualization and
pathology diagnosis and treatment of a specific organ, it is essential to first image normal
tissue from that organ and then reference the resulting OCT images to parallel histology.
Initial studies of laryngeal imaging using OCT have focused on the free edge and inferior
surface of the vocal folds. Figure A. 1 presents an OCT image taken along the inferior portion
of a pig vocal fold, as evidenced by the transition from free-edge non-glandular LP to
subglottal glandular LP observed in the OCT image and corresponding histological section.
This OCT image illustrates the ability of OCT to allow visualization of the epithelium,
basement membrane, and certain structural features such as glands and vessels. Note in
particular that local thickness and transparency of the vocal fold epithelium can be readily
deduced from these images, implying that OCT may prove useful for the diagnosis of
hyperplasia, early stage keratosis and papillomas, and other pathologies resulting in epithelial
abnormalities not normally visible by conventional light endoscopy until an advanced stage.
Since many laryngeal pathologies originate at the epithelial-LP border, the ability to observe
basement membrane integrity via OCT imaging may have important implications for the use
of this technology in aiding the diagnosis and monitoring of such laryngeal disorders.
A
Figure A.1: Correlation of pig vocal fold OCT images with parallel histology. (A) OCT image of the
inferior surface of a pig vocal fold; (B) corresponding H&E histology section; (C) phase-contrast viewing
of the stained histology section. Scale bars=150pm.
A.4 Polarization sensitive optical coherence tomography
A monochromatic light wave carries three potential sources of information contained in the
amplitude, phase, and polarization state of its electric field vector. Conventional OCT, by
detecting only the intensity of the interference pattern resulting from interaction of the sample
and reference optical beams, fails to quantify the effects of tissue on the polarization state of
the sample light beam. An adjunct to conventional OCT, known as polarization sensitive
OCT (PS-OCT), therefore, has focused on exploiting the information contained in the
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polarization state of the light backreflected or backscattered from the sample relative to that of
the reference beam to obtain information about the tissue microstructure.
In order to appreciate the power of PS-OCT and its potential applications, it is helpful to
describe briefly the main mechanisms by which tissue alters the polarization state of light.
Two mechanisms dominate the changes in the polarization state of light propagating through
biological tissue: scattering and birefringence. Scattering changes the polarization of light
mainly in a random manner, so it is generally not useful in mapping tissue structure.
Organized linear structures, on the other hand, such as collagen fiber bundles with a clear
orientation, can exhibit birefringence, resulting in a predictable change in polarization state.
Many biological tissues exhibit birefringence, such as tendons, muscle, nerve, bone, cartilage
and teeth [9]. Since changes in birefringence may, for instance, indicate changes in
functionality, structure, or viability of tissues, PS-OCT images may contain information
which can be used to evaluate tissue microstructure and health beyond the level possible with
the use of OCT alone [10].
The potential implications for clinical laryngology of the sensitivity of PS-OCT to organized
linear structures, such as oriented collagen fiber bundles, are numerous. To illustrate, the
human vocal fold LP is generally subdivided into the superficial, intermediate, and deep
layers, each layer having a characteristic composition and functionality. The relative
thickness and integrity of these various layers appear to have a profound impact on voice.
This idea is supported by the fact that the average adult will experience marked thinning of
the superficial LP relative to the intermediate and deep layers with increasing age [11], with a
concomitant reduction in voice quality.
Histological studies of normal adult human vocal fold tissue have repeatedly noted increased
density and orientation of collagen fibers as one progresses from more superficial to deeper
LP layers [11]. The collagen fibers present in the superficial layer appear to be loose and
randomly oriented. PS-OCT, due to its sensitivity to oriented collagen fiber bundles, may
thus allow indirect detection of these LP layers in situ and hence monitoring and possibly
improved treatment of voice aging. In the case of vocal fold scarring, the biomechanical
integrity of the LP is disrupted, resulting in reduced vocal fold pliability and thus decreased
vocal range and quality. Scar tissue has collagen fiber orientation and density that is
generally distinct from that of normal tissue, and therefore PS-OCT also may prove useful in
visualizing, localizing, and treating vocal fold scar within the LP. These capabilities could
have significant impact on the area of voice management.
Figure A.2 compares a PS-OCT image of the free-edge/inferior surface of a human vocal fold
with the corresponding OCT image and histological section. Note the banding pattern
apparent in the PS-OCT image of the vocal fold: a transition from white to black banding
indicates a change in the polarization state of light. In particular, observe the marked increase
in thickness of the initial white band in the leftmost portion of the PS-OCT image
(corresponding to free-edge tissue) relative to that in the image portion corresponding to
increasingly subglottic tissue. The spatial location of this increase in initial white-band
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thickness correlates closely with increasing prominence of the vocal fold superficial LP in the
same region. Due to lack of an adequate data set, it is not possible for these spatial banding
patterns to be definitively interpreted at this point. However, it can be hypothesized that the
increased thickness of the initial white band as one moves superiorly from subglottic to free-
edge tissue is due in part to the presence of a rich layer of more randomly oriented collagen in
the increasingly free-edge region which is not present in the more subglottic space. As such,
the more conspicuous this slowed transition from white to black banding in the region of the
superficial LP, the more significant the superficial layer may be in terms of overall LP
composition.
Figure A.2: Comparison of PS-OCT and OCT human vocal fold images. (A) H&E histology section of the
inferior surface of a human vocal fold; (B); corresponding OCT image; (C) corresponding PS-OCT
image. Scale bar=150m.
Again, it must be stressed that further studies need to be carried out to determine what the
observed vocal fold polarization patterns truly indicate. In the case that these studies show
that the relative thickness and/or health of the LP layers can indeed be indirectly assessed by
this imaging adjunct, PS-OCT could prove very useful to the study of LP health and in the
development of targeted scar treatment strategies.
A.5 Summary
OCT and OCT-adjuncts have potential for improving the diagnosis and management of vocal
fold pathology as well as for in vivo implant monitoring. Conventional OCT studies of
healthy laryngeal tissues ex vivo have demonstrated that OCT can detect spatial changes in
the thickness and transparency of the epithelium; the content of the connective tissues in
terms of glands and vessels; pronounced transitions in connective tissue type; and the
architecture of the basement membrane. PS-OCT holds promise for permitting indirect
"visualization" of the layers of the vocal fold LP as well as of vocal fold scar beds. In
addition, a number of other OCT adjuncts, such as spectroscopic OCT [12] and phase
dispersion tomography [13] exist or are currently in development, each with distinct imaging
advantages and capabilities over conventional OCT imaging.
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Appendix B. Vocal Fold Cell Isolation and Culture
B.1 Introduction
The isolation of a tissue's primary extracellular matrix (ECM)-producing cells is a necessary
precursor to in vitro analysis of materials to be used for replacement or restoration of that
tissue. Thus, two protocols were compared for effectiveness in isolating high purity
populations of vocal fold fibroblast-like cells, the primary ECM-producing cells in the vocal
fold lamina propria (LP) [1]. In addition, several media types were compared for their effects
on vocal fold fibroblast growth, morphology, and viability.
B.2 Cell isolation
Vocal fold fibroblasts were isolated using two different methodologies:
(1) Primary explant:
This procedure relies on cell migration out of the explant tissue. Since
fibroblast-like cells have been observed to migrate faster than many other cell
types, explant culture has potential for yielding high purity fibroblast
populations given appropriate culture conditions [2].
(2) Enzymatic release of cells:
The dermis is a tissue containing many of the same cell types as the vocal fold
LP, including myofibroblasts, endothelial cells, leukocytes, and ECM-
producing fibroblasts. A commonly used method for isolating dermal
fibroblasts involves the following procedure: treatment of the skin biopsy
tissue with dispase to dissociate the overlying epithelium from dermis followed
by trypsinization of the dermis to release ECM-associated cells [2]. The more
rapid proliferation of fibroblasts over contaminant cell types is apparently
sufficient to result in high purity fibroblast cell populations after the first
several passages.
Ideally, verification of the purity of a primary cell population would involve antibody-based
examination of cell types. Although there are no specific cell markers for pig fibroblast-like
cells on the market, antibodies specific for many of the potential contaminant cell types, such
as leukocytes and endothelial cells, do exist. Thus, the purity of the resulting cell populations
can still be assessed by using immunolabelling to verify the absence of contaminant cell
populations. The assessments made in this study, however, were based on morphological
examination of cell population rather than more rigorous antibody-based examination, due to
difficulty in locating appropriate pig negative and positive control cell populations for the
antibody-based assays.
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Based on visual assessments of cell purity, dispase-trypsin treatment of the vocal fold
generally resulted in the significant levels of contaminant cell types that did not appear to be
eliminated with passaging. Although fibroblast-like cells were the primary cell types present,
contaminant cells would form cell "islands" within surrounding fibroblast-like cells. These
cell islands would usually either form raised multicellular structures or flat sheets of fully
juxtaposed cells (see Figure B.1), behavior not typically associated with a pure fibroblast
population. These cell islands were absent from primary explant cultures, which appeared to
yield a relatively uniform cell population in terms of cell morphology and intercellular
spacing/organization. These results imply that purity of isolated vocal fold fibroblast-like cell
populations may be improved in primary explant versus dispase-trypsin procedures.
Figure B.1 Contaminant cell populations characteristic of dispase-trypsin isolation procedures.
Contaminant cell islands/clusters are circled in white. (A) represents fully-juxtaposed monolayer
contaminant cells; (B) represents contaminant cells forming a raised structure.
B.3 Analysis of media types
Previous in vitro studies of vocal fold fibroblasts have used either Dulbecco's Modified Eagle
Medium (DMEM) or Eagle's Minimal Essential Medium (MEM) supplemented with fetal
bovine serum (FBS) [3-6], both of which are standard media for fibroblast cell culture.
However, comparison of the effects of various media types on vocal fold fibroblasts cell
morphology and growth has not been carried out. Thus, several different media types were
examined for their effects on vocal fold fibroblast proliferation, survival on prolonged
exposure to stress, and morphology:
1.) DMEM +10% FBS +
[100 Units/mL penicillin + 100 gg/mL streptomycin] (100 P/S)
2.) DMEM +10% FBS + 100 P/S
3.) MEM + 10% FBS +100 P/S
4.) MEM + 0.1mM non-essential amino acids + 10% FBS +100 P/S
5.) Fibroblast Basal Medium (FBM, Cambrex) +10% FBS +100 P/S
6.) FBM + Ing/mL hFGF-B + 5 gg/mL insulin + 2%FBS +100 P/S
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Results for media 1, 4, 5, and 6 will be focused on in the discussion below. For brevity, the
above media will be referred to as: (1) DMEM, (4) MEM+neaa, (5) FBM, and (6) FBM2.
Table B. 1 indicates relative proliferation of vocal fold fibroblasts in various media types.
Primary pig vocal fold fibroblasts originating from a single passage 6 parent flask were
seeded at equal densities among daughter flasks. Groups of daughter flasks received different
media types, with media changed every 3 days. After 6 days of growth, cells from each
media group were trypsinized, counted using a hemacytometer and tested for viability by
trypan blue exclusion. As indicating in Figure 1, cells cultured in media 1,4, and 5
proliferated at a lower rate than those in FBM2. (Cell proliferation in media 2 and 3 was also
lower than that in FBM2, data not shown.) The increased proliferation in FBM2 is not
unexpected due to the presence of hFGF-B in this media. As can be seen from Tables B. 1 and
B.2, viability both within 30 minutes post-trypsinization and 3 hours post-trypsinization
remained greater than 95% for cells grown in FBM2 media, whereas viability of cells grown
in the remaining media types fell to under 90% 3 hours post-trypsinization. Thus cell
viability upon extended exposure to stress appears to be higher in FBM2 media than in the
remaining media types assayed, a result which is important for ensuring high initial cell
viability in encapsulation studies.
In addition to increased proliferative capacity and improved survival, cells grown in FBM2
media were on average smaller and grew more regularly, in terms of cell shape and
intercellular spacing, than cells grown in the remaining media types (see Figure B.2). Due at
least in part to the increased cell size, cells grown in media 1-5 did not reach the same cell
density and number at confluence as those grown in FBM2. The marked alterations in cell
size and morphology with media type observed for pig vocal fold fibroblasts were not noted
for dermal fibroblasts grown in DMEM versus FBM media. This observation was based on
only a single human dermal fibroblast sample, and therefore further and more detailed
examination would be required to verify this observation. However, if this disparity between
dermal and vocal fold fibroblast responses to media types holds under further
experimentation, it may suggest the existence non-environmentally induced differences
between dermal and vocal fold fibroblasts.
Table B.1: Cell number and viability by media type. Cell numbers were normalized by FBM2 cell
numbers. Cell viability was assessed within 30 minutes post-trypsinization.
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Medium Cells /cells in FBM2 Cell viability
FBM2 1 97%
FBM .301 93%
DMEM .250 93%
MEM+neaa .203 94%
Figure B.2 Cell size and morphology by media type. Scale bars = 200 pm. (A) DMEM, (B) FBM, (C)
FBM2, (D) MEM+neaa.
Independent of media type, a noticeable decrease in the proliferation rate of primary explant
pig vocal fold fibroblasts generally began following passage 4. Changes in cell morphology
were also observed as the cells became senescent. Most notably, increased lamellipodia and
intracellular vacuolization were noted with increased age (data not shown).
Table B.2: Cell viability following exposure to prolonged stress. Cell viability was assessed 3 hours post-
trypsinization following two centrifugations at 300g for 6 minutes each (typical conditions in initial
encapsulation experiments).
Medium Cell viability
FGM2 97%
FBM 90%
DMEM 87%
MEM+neaa 80%
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B.4 Recommendations
Based on the above results, FBM2 appears to be the optimal medium of the media types
examined in terms of cells growth up to the point of cell-encapsulation. Aside from yielding
improved cell proliferation and viability upon prolonged exposure to stress, FBM2 is
attractive because of its reduced levels of FBS, making FBM2 a more defined media than the
remaining media types analyzed. However, FBM2 contains hFGF-B and insulin, additives
that may not be appropriate for optimal in vitro post-encapsulation studies. The use of this
media post-encapsulation requires further investigation, although its utility in these studies
will likely depend on experimental design.
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